<!DOCTYPE html>
<html lang="en"><head>
  <meta charset="utf-8">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <title>Multicenter Collaboratives | Pediatric Urology Book</title>
  
  <!-- SEO stuff -->
  <meta name="generator" content="Jekyll v4.2.2" />
  <meta name="author" content="Arlen AM, Gundeti MS, López P-J, Rove KO" />
  <meta name="description" content="Chapter 62 provides a comprehensive rundown of all multicenter collaboratives that are ongoing as of 2023." />
  <meta property="article:published_time" content="2023-04-28" />
  <link rel="canonical" href="https://beta.pediatricurologybook.com/book/chapters/11-62_multicenter-collaboratives/" />
  <script type="application/ld+json">
    {
      "@context":"https://schema.org",
      "@type":"WebSite",
      "editor": [
        {
          "@type":"Person",
          "email":"angela.arlen@yale.edu",
          "affiliation":[
            {
              "@type":"Organization",
              "url":"https://medicine.yale.edu/",
              "name":"Yale University School of Medicine"
            },{
              "@type":"Organization",
              "url":"https://www.ynhh.org/",
              "name":"Yale-New Haven Hospital"
            }
          ],
          "familyName": "Arlen",
          "givenName": "Angela",
          "additionalName":"M.",
          "name":"Angela M. Arlen"
        }
      ,{
          "@type":"Person",
          "email":"mgundeti@surgery.bsd.uchicago.edu",
          "affiliation":[
            {
              "@type":"Organization",
              "url":"https://www.uchicagomedicine.org/",
              "name":"University of Chicago Medical Center"
            },{
              "@type":"Organization",
              "url":"https://www.uchicagomedicine.org/comer",
              "name":"Comer Children’s Hospital"
            }
          ],
          "familyName": "Gundeti",
          "givenName": "Mohan",
          "additionalName":"S.",
          "name":"Mohan S. Gundeti"
        }
      ,{
          "@type":"Person",
          "email":"pejotalopez@gmail.com",
          "affiliation":[
            {
              "@type":"Organization",
              "url":"https://www.hegc.gob.cl/",
              "name":"Hospital Exequiel González Cortés & Clinica Alemana "
            },{
              "@type":"Organization",
              "url":"https://www.hrrio.cl/web2/",
              "name":"Hospital de Niños Roberto del Río"
            },{
              "@type":"Organization",
              "url":"https://www.uchile.cl/",
              "name":"Universidad de Chile"
            }
          ],
          "familyName": "López",
          "givenName": "Pedro-José",
          "name":"Pedro-José López"
        }
      ,{
          "@type":"Person",
          "email":"kyle.rove@childrenscolorado.org",
          "affiliation":[
            {
              "@type":"Organization",
              "url":"https://www.childrenscolorado.org",
              "name":"Children's Hospital Colorado"
            },{
              "@type":"Organization",
              "url":"https://medschool.cuanschutz.edu",
              "name":"University of Colorado, School of Medicine"
            }
          ],
          "familyName": "Rove",
          "givenName": "Kyle",
          "additionalName":"O.",
          "name":"Kyle O. Rove"
        }
      ],
      "author":[
        {
          "@type":"Person",
          "email":"Kiersten.Craig@cchmc.org ",
          "affiliation":[
            {
              "@type":"Organization",
              "url":"https://www.cincinnatichildrens.org/",
              "name":"Cincinnati Children’s Hospital Medical Center"
            }
          ],
          "familyName": "Craig",
          "givenName": "Kiersten",
          "additionalName":"M.",
          "name":"Kiersten M. Craig"
        }
      ,{
          "@type":"Person",
          "email":"Andrew.Strine@cchmc.org",
          "affiliation":[
            {
              "@type":"Organization",
              "url":"https://www.cincinnatichildrens.org/",
              "name":"Cincinnati Children’s Hospital Medical Center"
            }
          ],
          "familyName": "Strine",
          "givenName": "Andrew",
          "additionalName":"C.",
          "name":"Andrew C. Strine"
        }
      ],
      "datePublished":"2023-04-28",
      "dateModified":"2023-04-23",
      "description":"Chapter 62 provides a comprehensive rundown of all multicenter collaboratives that are ongoing as of 2023.",
      "image":"https://beta.pediatricurologybook.com/assets/thumbs/11-62_multicenter-collaboratives.md.png",
      "headline":"Multicenter Collaboratives",
      "name":"Pediatric Urology Book",
      "url":"https://beta.pediatricurologybook.com/book/chapters/11-62_multicenter-collaboratives/"
    }
  </script>

  <!-- I18n headers -->
  <meta http-equiv="Content-Language" content="en">
<link rel="alternate" hreflang="en" href="https://beta.pediatricurologybook.com/book/chapters/11-62_multicenter-collaboratives/"/>
<link rel="alternate" hreflang="es" href="https://beta.pediatricurologybook.com/es/book/chapters/11-62_multicenter-collaboratives/"/>
<link rel="alternate" hreflang="zh" href="https://beta.pediatricurologybook.com/zh/book/chapters/11-62_multicenter-collaboratives/"/>
<link rel="alternate" hreflang="pt" href="https://beta.pediatricurologybook.com/pt/book/chapters/11-62_multicenter-collaboratives/"/>

  <!-- Favicon -->
  <link rel="icon" href="https://beta.pediatricurologybook.com/favicon.ico" type="image/x-icon" > <!-- 32×32 -->
  <link rel="icon" href="https://beta.pediatricurologybook.com/assets/site-img/favicons/icon.svg" type="image/svg+xml">    <!-- res independent -->
  <link rel="apple-touch-icon" href="https://beta.pediatricurologybook.com/assets/site-img/favicons/apple-touch-icon.png"> <!-- 180×180 -->
  <link rel="manifest" href="/manifest.webmanifest">
  
  <!-- Mobile Metas -->
  <meta name="viewport" content="width=device-width, initial-scale=1, minimum-scale=1.0, shrink-to-fit=no">
  
  <!-- Social Media Tags -->
  <meta name="twitter:card" content="summary_large_image" />
  <meta name="twitter:image" content="https://beta.pediatricurologybook.com/assets/thumbs/11-62_multicenter-collaboratives.md.png" />
  <meta name="twitter:site" content="@PedUrologyBook" />
  <meta name="twitter:title" content="Multicenter Collaboratives" />
  <meta name="twitter:description" content="Chapter 62 provides a comprehensive rundown of all multicenter collaboratives that are ongoing as of 2023." />
  <meta property="og:locale" content="en" />
  <meta property="og:site_name" content="Pediatric Urology Book" />
  <meta property="og:title" content="Multicenter Collaboratives" />
  <meta property="og:url" content="https://beta.pediatricurologybook.com/book/chapters/11-62_multicenter-collaboratives/" />
  <meta property="og:image" content="https://beta.pediatricurologybook.com/assets/thumbs/11-62_multicenter-collaboratives.md.png" />
  <meta property="og:description" content="Chapter 62 provides a comprehensive rundown of all multicenter collaboratives that are ongoing as of 2023." />
  
  <!-- Vendor CSS -->
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/vendor/bootstrap/css/bootstrap.min.css">
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/vendor/fontawesome-pro/css/all.min.css">
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/vendor/animate/animate.min.css">
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/vendor/rs-plugin/css/navigation.css">
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/vendor/owl.carousel/assets/owl.carousel.min.css">
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/vendor/owl.carousel/assets/owl.theme.default.min.css">
  
  <!-- Theme CSS -->
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/css/theme.css">
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/css/theme-elements.css">

  <!-- Skin CSS -->
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/css/skins/skin-pub.css"> 
  
  <!-- Theme Custom CSS -->
  <link rel="stylesheet" href="https://beta.pediatricurologybook.com/assets/css/custom.css">
  
  <!-- JS Libraries -->
  <script src="https://beta.pediatricurologybook.com/assets/vendor/modernizr/modernizr.min.js"></script>
</head>
<body data-plugin-page-transition>

    <div class="body" aria-label="Content">    
    
    <header id="header" data-plugin-options="{'stickyEnabled': true, 'stickyEnableOnBoxed': true, 'stickyEnableOnMobile': true, 'stickyStartAt': 108, 'stickySetTop': '-109px', 'stickyChangeLogo': true}">
      <div class="header-body">
        <div class="header-container container">
          <div class="header-row">
            <div class="header-column">
              <div class="header-row">
                <div class="header-logo">
                  <a class="site-title" rel="author" href="https://beta.pediatricurologybook.com/">
                    <img width="254" height="165" data-sticky-width="126" data-sticky-height="80" data-sticky-top="95" alt="Pedatric Urology Book" src="https://beta.pediatricurologybook.com/assets/site-img/pediatricurologybook-new.svg">
                  </a>
                </div>
              </div>
            </div>
            <div class="header-column justify-content-end">
              <div class="header-row pt-3 mb-3">
                <nav class="header-nav-top">
                  <ul class="nav nav-pills">
                    <li class="nav-item nav-item-anim-icon d-none d-md-block">
                      <a class="nav-link pl-0" href="https://beta.pediatricurologybook.com/about-us/"><i class="fa fa-angle-right pr-1"></i>About Us</a>
                    </li>
                    <li class="nav-item nav-item-anim-icon d-none d-md-block">
                      <a class="nav-link" href="https://beta.pediatricurologybook.com/contact-us/"><i class="fa fa-angle-right pr-1"></i>Contact Us</a>
                    </li>
                    <li class="nav-item dropdown nav-item-left-border d-block nav-item-left-border-remove nav-item-left-border-md-show">
                      
                      <a class="nav-link" href="#" role="button" id="dropdown-language" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">
                        <i class="fas fa-globe-americas"></i> English
                        <i class="fas fa-angle-down"></i>
                      </a>
                      <div class="dropdown-menu" aria-labelledby="dropdown-language">
                        
                          
                            
                          
                          
                          
                          
                          <a class="dropdown-item" href="https://beta.pediatricurologybook.com/es/book/chapters/11-62_multicenter-collaboratives/">Español</a>
                          
                        
                          
                          
                          
                          
                          <a class="dropdown-item" href="https://beta.pediatricurologybook.com/zh/book/chapters/11-62_multicenter-collaboratives/">简体中文</a>
                          
                        
                          
                          
                          
                          
                          <a class="dropdown-item" href="https://beta.pediatricurologybook.com/pt/book/chapters/11-62_multicenter-collaboratives/">Português</a>
                          
                        
                      </div>
                    </li>
                  </ul>
                </nav>
                <div class="header-nav-features header-nav-features-no-border header-nav-features-md-show-border d-none d-md-inline-flex">
                    <div class="simple-search input-group w-auto">
                      <input class="form-control text-1" id="search-input" name="q" type="text" value="" placeholder="Search...">
                      <span class="input-group-btn">
                        <button class="btn" type="submit">
                          <i class="fa fa-search"></i>
                        </button>
                      </span>
                      <ul id="search-results">
                      </ul>
                    </div>
                </div>
              </div>
              <div class="header-row">
                <div class="header-nav pt-1">
                  <div class="header-nav-main header-nav-main-effect-1 header-nav-main-sub-effect-1">
                    <nav class="collapse">
                      <ul class="nav nav-pills" id="mainNav">
                        <li><a href="https://beta.pediatricurologybook.com/"><i class="fas fa-home pr-1"></i>Home</a></li>
                        <li><a href="https://beta.pediatricurologybook.com/book/"><i class="fas fa-book pr-1"></i>Read The Book</a></li>
                        <li><a href="https://beta.pediatricurologybook.com/editors/"><i class="fas fa-pen-fancy pr-1"></i>Editors</a></li>
                        <li><a href="https://beta.pediatricurologybook.com/contributors/"><i class="fas fa-code-branch pr-1"></i>Contributors</a></li>
                        <li><a href="https://beta.pediatricurologybook.com/sponsors/"><i class="fas fa-user-md pr-1"></i>Sponsors</a></li>
                      </ul>
                    </nav>
                  </div> <!-- end header-nav-main -->
                  <button class="btn header-btn-collapse-nav" data-toggle="collapse" data-target=".header-nav-main nav">
                      <i class="fas fa-bars"></i>
                  </button>
                </div> <!-- end header-nav -->
              </div> <!-- end header-row -->
            </div> <!-- end header-column -->
          </div> <!-- end header-row -->
        </div> <!-- end header-container -->
      </div> <!-- end header-body -->
    </header>
        
    
    
    
    
    
    <div role="main" class="main">
      <section class="page-header page-header-modern bg-color-primary page-header-md">
        <div class="container">
          <div class="row">
            <div class="col-md-8 order-2 order-md-1 align-self-center p-static">
              <h1>62: Multicenter Collaboratives</h1>
            </div>
            
            <div class="col-md-4 order-1 order-md-2 align-self-center">
              <ul class="breadcrumb d-block text-md-right breadcrumb-light">
              
                <li><a href="https://beta.pediatricurologybook.com/">Home</a></li>
              
                <li><a href="https://beta.pediatricurologybook.com/book/">Book</a></li>
              
                <li class="active"><a href="https://beta.pediatricurologybook.com/book/#beyond-the-frontier-in-pediatric-urology">Section 11: Beyond The Frontier in Pediatric Urology</a></li>
              </ul>
            </div>
          </div>
        </div>
      </section>
      <div class="container chapter chapter-11-62">
        <div class="row">
          <div class="col-lg-3 order-2 order-lg-1 mt-4 mt-lg-0 chapter-toc">
            <aside class="sidebar">
              <h5 class="font-weight-bold no_toc">Chapter Contents</h5>
    
            <ul class="nav nav-list flex-column mb-5">
<li class="nav-item toc-h2"><a href="#introduction">Introduction</a></li>
<li class="nav-item toc-h2"><a href="#the-society-for-fetal-urology">The Society for Fetal Urology</a></li>
<li class="nav-item toc-h2"><a href="#national-spina-bifida-patient-registry">National Spina Bifida Patient Registry</a></li>
<li class="nav-item toc-h2"><a href="#multi-institutional-bladder-exstrophy-consortium">Multi-Institutional Bladder Exstrophy Consortium</a></li>
<li class="nav-item toc-h2"><a href="#urologic-management-to-preserve-initial-renal-function-protocol-for-young-children-with-spina-bifida">Urologic Management to Preserve Initial Renal Function Protocol for Young Children with Spina Bifida</a></li>
<li class="nav-item toc-h2"><a href="#pediatric-urology-robotic-surgery">Pediatric Urology Robotic Surgery</a></li>
<li class="nav-item toc-h2"><a href="#pediatric-urologists-researching-surgical-outcomes-using-health-information-technology">Pediatric Urologists Researching Surgical Outcomes Using Health Information Technology</a></li>
<li class="nav-item toc-h2"><a href="#pediatric-urology-midwest-alliance">Pediatric Urology Midwest Alliance</a></li>
<li class="nav-item toc-h2"><a href="#prevention-of-urinary-stones-with-hydration-push-trial">Prevention of Urinary Stones with Hydration (PUSH) Trial</a></li>
<li class="nav-item toc-h2"><a href="#pediatric-urology-recovery-after-surgery-endeavor">Pediatric Urology Recovery after SUrgery Endeavor</a></li>
<li class="nav-item toc-h2"><a href="#gonadoblastoma-and-invasive-germ-cell-tumors">Gonadoblastoma and Invasive Germ Cell Tumors</a></li>
<li class="nav-item toc-h2"><a href="#pediatric-kidney-stone-care-improvement-network">Pediatric KIDney Stone Care Improvement Network</a></li>
<li class="nav-item toc-h2"><a href="#western-pediatric-urology-consortium">Western Pediatric Urology Consortium</a></li>
<li class="nav-item toc-h2"><a href="#traumatic-renal-injury-collaboration-for-kids">Traumatic Renal Injury Collaboration for Kids</a></li>
<li class="nav-item toc-h2"><a href="#conclusion">Conclusion</a></li>
<li class="nav-item toc-h2"><a href="#key-points">Key Points</a></li>
<li class="nav-item toc-h2"><a href="#references">References</a></li>
</ul>
            
            
            
            </aside>
          </div>
          <div class="col-lg-9 order-1 order-lg-2 chapter-body">
            <p class="time-to-read"><i class="fas fa-circle-info pr-2"></i><em>This chapter will take approximately 28 minutes to read.</em></p><div class="attribution">
    <div class="authors">
        By <span class="break-avoid ws-nowrap"><span class="author-name">
    <a href="/contributors/#craig-kiersten-m">Kiersten M. Craig, MD, MSE</a>
</span> <a href="#" id="social-drop-139" class="social-drop-down" aria-haspopup="true" aria-expanded="false"><i class="fa-regular fa-signal-stream"></i></a> <sup>1</sup></span>&nbsp; &amp; <span class="break-avoid ws-nowrap"><span class="author-name">
    <a href="/contributors/#strine-andrew-c">Andrew C. Strine, MD, MPH</a>
</span> <a href="#" id="social-drop-140" class="social-drop-down" aria-haspopup="true" aria-expanded="false"><i class="fa-regular fa-signal-stream"></i></a> <sup>2</sup></span></div><ul class="thumb-info-social-icons" id="social-drop-139">
    
    <li class="social-icons-email"><a href="mailto:Kiersten.Craig@cchmc.org " target="_blank" title="Email"><i class="fas fa-envelope"></i></a></li>
    
    
    
    
    
    
    
    
    
    
    
    
    <li class="social-icons-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/?sort=date&term=Craig+KM&cauthor_id=32979705" target="_blank" title="PubMed"><i class="ai2 ai-pubmed"></i></a></li>
</ul><ul class="thumb-info-social-icons" id="social-drop-140">
    <li class="social-icons-website"><a href="https://www.cincinnatichildrens.org/bio/s/andrew-strine" target="_blank" title="Website"><i class="fas fa-link"></i></a></li>
    <li class="social-icons-email"><a href="mailto:Andrew.Strine@cchmc.org" target="_blank" title="Email"><i class="fas fa-envelope"></i></a></li>
    
    
    
    
    
    
    
    
    
    
    
    
    <li class="social-icons-pubmed"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=strine+ac" target="_blank" title="PubMed"><i class="ai2 ai-pubmed"></i></a></li>
</ul><ol class="author-affiliation-list"><li class="author-affiliation" value="1"><span>
    <address>Division of Pediatric Urology , <a href="https://www.cincinnatichildrens.org/">Cincinnati Children’s Hospital Medical Center</a>, Cincinnati, OH, USA
    </address>
</span></li><li class="author-affiliation" value="2"><span>
    <address>Division of Pediatric Urology , <a href="https://www.cincinnatichildrens.org/">Cincinnati Children’s Hospital Medical Center</a>, Cincinnati, OH, USA
    </address>
</span></li></ol>
</div>

                
            <h2 id="introduction">
<a class="anchor" href="#introduction" aria-hidden="true"><span class="octicon octicon-link"></span></a>Introduction</h2>

<p>The quality of research in pediatric urology is historically low due to a predominance of small retrospective studies at single centers. The rarity and complexity of many conditions create a challenge for high-quality research. While the feasibility of randomized controlled trials (<abbr title="randomized controlled trials">RCTs</abbr>) in the pediatric surgical literature is debated, the need for more prospective study design and multicenter collaboration is clear. A prospective study design decreases the potential for bias, while a multicenter collaboration allows for a larger sample size to increase the statistical power and more generalizability. A multicenter collaboration is also benefitial to share the workload for research, provide more educational and funding opportunities, and build a relationship with the participating centers through a shared experience. Furthermore, it can shift the referral patterns and build a practice, as referring providers as well as patients and families understand which centers have an expertise and are able to achieve an excellent outcome for a particular condition. However, a multicenter collaboration is not without its challenges, such as a significant committment of time and resources as well as the need for leadership and coordination across mulitple centers to complete the necessary tasks in a timely fashion. The purpose of this chapter is to review the recent multicenter collaboratives in pediatric urology in the United States (<abbr title="United States">US</abbr>), including those registered with the Societies for Pediatric Urology and others that have made a significant contribution. While there are numerous multicenter collaboratives in pediatirc urology oncology, those are ouside the scope for this chapter.</p>

<h2 id="the-society-for-fetal-urology">
<a class="anchor" href="#the-society-for-fetal-urology" aria-hidden="true"><span class="octicon octicon-link"></span></a>The Society for Fetal Urology</h2>

<p>The <abbr title="Society of Fetal Urology">SFU</abbr> hydronephrosis registry is a prospective registry that was developed in 2006. Its objective is to study the natural history of prenatal hydronephrosis and to guide the management of these patients. The participating centers include Children’s Hospital of Richmond at Virginia Commonwealth University, Children’s Hospital of Orange County, Connecticut Children’s Medical Center, McMaster University, University of Iowa, University of Virginia, and University of Wisconsin.</p>

<p>Zee <em>et al</em> initially sought to assess the incidence and identify the risk factors for urinary tract infection (<abbr title="urinary tract infection">UTI</abbr>) in a study of 213 patients with a prenatal diagnosis of hydronephrosis between September 2008 and October 2015. A total of 18 (8%) patients developed a <abbr title="urinary tract infection">UTI</abbr> during the study period, most of which occurred during their first year of life (89%). Only a female sex (<abbr title="odds ratio">OR</abbr> 8.4, 95% <abbr title="confidence interval">CI</abbr> 2.8–24.7) was an independent predictor of <abbr title="urinary tract infection">UTI</abbr> on multivariate analysis. When stratified by sex, both the grade of hydronephrosis (<abbr title="odds ratio">OR</abbr> 8.3, 95% <abbr title="confidence interval">CI</abbr> 1.1–61.9) and circumcision status (<abbr title="odds ratio">OR</abbr> 23.2, 95% <abbr title="confidence interval">CI</abbr> 2.2–238.9) were an independent predictor of <abbr title="urinary tract infection">UTI</abbr> in male patients on multivariate analysis.<a class="citation" href="#zee2016a"><span style="vertical-align: super">1</span></a></p>

<p>In a subsequent study of 248 patients over the same period, Zee <em>et al</em> assessed the resolution of prenatal hydronephrosis after birth. The time to resolution favored a lower grade of hydronephrosis with a median follow-up of 15 months (<abbr title="interquartile range">IQR</abbr> 7–24). A majority of hydronephrosis resolved or improved within 3 years, and surgical intervention was only required in 14 (8%) patients.<a class="citation" href="#zee2017a"><span style="vertical-align: super">2</span></a></p>

<p>Holzman <em>et al</em> also sought to determine the definition of clinically relevant hydroureter, its association with <abbr title="urinary tract infection">UTI</abbr>, and the impact of continuous antibiotic prophylaxis (<abbr title="continuous antibiotic prophylaxis">CAP</abbr>) in a study of 237 patients with ureteral measurements on ultrasound between 2008–2020. Among patients who did not have vesicoureteral reflux (<abbr title="vesicoureteral reflux">VUR</abbr>) on voiding cystourethrogram, a ureteral diameter ≥7 mm was an independent predictor of <abbr title="urinary tract infection">UTI</abbr> on multivariate analysis (<abbr title="hazard ratio">HR</abbr> 4.6, 95% <abbr title="confidence interval">CI</abbr> 1.1–19.5). <abbr title="continuous antibiotic prophylaxis">CAP</abbr> was aslo significantly protective against <abbr title="urinary tract infection">UTI</abbr> (<abbr title="hazard ratio">HR</abbr> 0.50, 95% <abbr title="confidence interval">CI</abbr> 0.28–0.87).<a class="citation" href="#holzman2021a"><span style="vertical-align: super">3</span></a></p>

<p>Chamberlin <em>et al</em> most recently assessed the incidence of <abbr title="urinary tract infection">UTI</abbr> and impact of <abbr title="continuous antibiotic prophylaxis">CAP</abbr> in a study of 801 patients with a history of isolated prenatal hydronephrosis (no hydroureter) between 2008-2020. A total of 34 (4.2%) patients developed a <abbr title="urinary tract infection">UTI</abbr> during the study period with a median follow-up of 1.6 years (<abbr title="interquartile range">IQR</abbr> 0.85–2.7). A female sex (<abbr title="hazard ratio">HR</abbr> 13, 95% <abbr title="confidence interval">CI</abbr> 3.8–44), circumcision status (<abbr title="hazard ratio">HR</abbr> 5.1, 95% <abbr title="confidence interval">CI</abbr> 1.4–18), and <abbr title="Society of Fetal Urology">SFU</abbr> grade 3-4 hydronephrosis (<abbr title="hazard ratio">HR</abbr> 2.0, 95% <abbr title="confidence interval">CI</abbr> 0.99–4.0) were each an independent predictor of <abbr title="urinary tract infection">UTI</abbr> on multivariate analysis. The risk of <abbr title="urinary tract infection">UTI</abbr> was not significantly different between those who received and did not receive <abbr title="continuous antibiotic prophylaxis">CAP</abbr> (4.0% vs. 4.3%) after adjusting for the sex, circumcision status, and grade of hydronephrosis on multivariate analysis (<abbr title="hazard ratio">HR</abbr> 0.72, 95% <abbr title="confidence interval">CI</abbr> 0.34-1.5).<a class="citation" href="#chamberlin2022a"><span style="vertical-align: super">4</span></a></p>

<h2 id="national-spina-bifida-patient-registry">
<a class="anchor" href="#national-spina-bifida-patient-registry" aria-hidden="true"><span class="octicon octicon-link"></span></a>National Spina Bifida Patient Registry</h2>

<p>Due to differences in the staffing, delivery of services, and care in spina bifida clinics across the <abbr title="United States">US</abbr>, the Professional Advisory Council of the Spina Bifida Association developed the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> at the Centers for Disease Control and Prevention in 2008. By providing the framework for a systematic approach to improve the quality of care, the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> collects comparative data on demographics, treatments, and outcomes for children, adolescents, and adults ≥21 years of age who attend the 21 participating spina bifida clinics in the <abbr title="United States">US</abbr>.</p>

<p>Two studies have assessed the variation in the surgical managements of patients in the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr>. Routh <em>et al</em> assesed the surgical management of neurogenic bowel in a study of 5,528 patients enrolled in the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> between 2009-2015. A total of 1,088 (19.7%) patients underwent a surgery for neurogenic bowel, including a Malone anterograde continence enema or cecostomy tube in 957 (17.3%) patients and an ileostomy or colostomy in 155 (2.8%) patients. An older age (p&lt;0.001), female sex (p=0.02), white race (p=0.002), myelomeningocele (<abbr title="myelomeningocele">MMC</abbr>) diagnosis (p=0.01), higher level of lesion (p&lt;0.001), mobility status (p=0.01), private insurance (p=0.002), and <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> clinic (p&lt;0.001) were each independently associated with an increased odds of surgery on multivariate analysis.<a class="citation" href="#routh2017a"><span style="vertical-align: super">5</span></a> Routh <em>et al</em> further assessed the surgical management of neurogenic bladder during the same study period. A total of 1,129 (20.4%) patients underwent a lower urinary tract reconstruction, including an augemntation cystoplasty in 703 (12.7%) patients, continent catheterizable channel in 382 (6.9%) patients, and bladder outlet procedure in 189 (3.4%) patients. The rates of lower urinary tract reconstruction widely varied from 12.1% to 37.9% among the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> clinics. An older age, female sex, <abbr title="myelomeningocele">MMC</abbr> diagnosis, mobility status, and <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> clinic (all p&lt;0.0001) were each independently associated with an increased odds of surgery on multivariate analysis.<a class="citation" href="#routh2018a"><span style="vertical-align: super">6</span></a> Both studies observed a wide variation in surgical management based on both clinical- and non-clinical factors.<a class="citation" href="#routh2017a"><span style="vertical-align: super">5,6</span></a></p>

<p>Several studies have also assessed the bladder and bowel continence of patients in the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr>. In a study of 3,252 patients ≥5 years of age enrolled in the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> between March 2009 and Septmeber 2012, Freeman <em>et al</em> reported that 1,326 (40.8%) patients were continent of urine with or without intervention during the day and that 1,398 (43.0%) patients had no involuntary leakage of stool with or without intervention during the day upon enrollment. The rates of bladder continence widely varied from 18.8% to 56.4% among the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> clinics. An older age, female sex, race/ethnicity, private insurance, and <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> clinic were each independently associated with bladder continence for the entire cohort and those meeting the criteria for bladder impairment on multivariate analysis. The rates of bowel continence also widely varied from 17.2% to 65.0% among the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> clinics. An older age, female sex, race/ethnicity, private insurance, and <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> clinic were each independently associated with bowel continence for the entire cohort and those meeting the criteria for bowel impairment on multivariate analysis. Both a sacral level of lesion when compared to a thoracic level (<abbr title="odds ratio">OR</abbr> 1.60, 95% <abbr title="confidence interval">CI</abbr> 1.12–2.20) as well as a non-ambulator when compoared to a community ambulator (<abbr title="odds ratio">OR</abbr> 0.76, 95% <abbr title="confidence interval">CI</abbr> 0.58–0.99) were independently associated with bowel continence in the entire cohort. A non-<abbr title="myelomeningocele">MMC</abbr> diagnosis was independently associated with bladder (<abbr title="odds ratio">OR</abbr> 1.69, 95% <abbr title="confidence interval">CI</abbr> 1.36–2.10) and bowel (<abbr title="odds ratio">OR</abbr> 1.76, 95% <abbr title="confidence interval">CI</abbr> 1.39–2.23) continence in the entire cohort as well.<a class="citation" href="#freeman2017a"><span style="vertical-align: super">7</span></a> In a subsequent study of 5,250 patients ≥5 years of age enrolled in the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> between 2009-2015, Lie <em>et al</em> assessed the bladder continence in a longitudinal fashion. By last follow-up, 1,178 (22.4%) patients underwent a lower urinary tract reconstruction, 4,833 (92.6%) patients used some form of bladder management, and 2,402 (45.8%) patients had no or less than 1 episode of daytime incontinence per month. An older age, female sex, race/ethnicity, non-<abbr title="myelomeningocele">MMC</abbr> diagnosis, lower level of lesion, mobility status, and private insurance (all p&lt;0.001) were each independently associated with bladder continence on multivariate analysis. Both a history of lower urinary tract reconstruction (<abbr title="odds ratio">OR</abbr> 1.9, 95% <abbr title="confidence interval">CI</abbr> 1.7–2.1) and any form of bladder management (<abbr title="odds ratio">OR</abbr> 3.8, 95% <abbr title="confidence interval">CI</abbr> 3.2–4.6) were also independently associated with bladder continence. The association between bladder management and continence was stronger for patients with a <abbr title="myelomeningocele">MMC</abbr> diagnosis than those with a non-<abbr title="myelomeningocele">MMC</abbr> diagnosis as well.<a class="citation" href="#liu2018a"><span style="vertical-align: super">8</span></a> Smith <em>et al</em> most recently focused on the ethnic disparities of bladder and bowel continence In a study of 4,364 patients between 5–21 years of age enrolled in the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> between 2009–2015. By last follow-up, the Hispanic/Latino population had a significantly lower rate of private insurance (18.2% vs. 58.0%), lower urinary tract reconstruction (18.1% vs. 22.1%), surgery for neurogenic bowel (11.7% vs. 25.1%), bladder continence (38.6% vs. 44.9%), and bowel continence (43.9% vs. 55.8%) as well as a significantly higher rate of cutaneous vesicostomies (7.5% vs. 5.8%). A Hispanic/Latino ethnicity (<abbr title="odds ratio">OR</abbr> 0.82, 95% <abbr title="confidence interval">CI</abbr> 0.72–0.94) remained independently associated with a decreased odds of bowel continence on multivariate analysis.<a class="citation" href="#smith2019a"><span style="vertical-align: super">9</span></a></p>

<p>Two studies have specifically focused on adult patients in the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> as well. Wiener <em>et al</em> assessed the bowel management and continence in a study of 5,209 patients ≥5 years of age enrolled in the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> between September 2008 and December 2015. When compared to children between 5-11 years of age and adolescents between 12-19 yeas of age, the adult population was significantly less likely to use a Malone anterograde continence enema (17.1%) or cecostomy tube (5.5%) as well as more likely to use digital stimulation (4.4%) or disimpaction (3.0%) or have undergone a colostomy (3.9%). A total of 767 (58.3%) adults had no or less than 1 episode of bowel incontinence per month, including 630 (55.6%) adults with a <abbr title="myelomeningocele">MMC</abbr> and 147 (74.9%) adults with a non-<abbr title="myelomeningocele">MMC</abbr> diagnosis (p&lt;0.0001). Only a lack of full or part-time employment (<abbr title="odds ratio">OR</abbr> 0.59, 95% <abbr title="confidence interval">CI</abbr> 0.42-0.83) was independently associated with bowel continence on multivariate analysis.<a class="citation" href="#wiener2017a"><span style="vertical-align: super">10</span></a> Wiener <em>et al</em> further assessed the bladder management and continence during the same study period. When compared to children between 5-11 years of age and adolescents between 12-19 yeas of age, the adult cohort was significantly more likely to use <abbr title="continuous antibiotic prophylaxis">CAP</abbr> (17.4%) and perform <abbr title="clean intermittent catheterization">CIC</abbr> (76.8%) as well as less likely to use an anticholinergic medication (47.7%) and void spontaneously (10.5%). The types of lower urinary tract reconstruction also widely varied among the cohorts, including a significantly higher rate of augmentation cystoplasty in adults (23.0%). A total of 661 (48.2%) adults had no or less than 1 episode of daytime incontinence per month, including 543 (45.8%) adults with a <abbr title="myelomeningocele">MMC</abbr> and 118 (63.1%) adults with a non-<abbr title="myelomeningocele">MMC</abbr> diagnosis (p&lt;0.0001). Bladder continence significantly improved with age in patients with a <abbr title="myelomeningocele">MMC</abbr> (p&lt;0.0001) but not in those with a non-<abbr title="myelomeningocele">MMC</abbr> diagnosis (p=0.12). Again only a lack of full or part-time employment (<abbr title="odds ratio">OR</abbr> 0.69, 95% <abbr title="confidence interval">CI</abbr> 0.49-0.95) was independently associated with bladder continence on multivariate analysis.<a class="citation" href="#"></a></p>

<p>Chu <em>et al</em> most recently assessed the surveillance of kidney function in a study of 5,445 patients registered in the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> between 2013–2018. A total of 3,384 (62.1%) patients underwent at least 1 renal ultrasound and serum creatinine within 2 years of follow-up. The rates for surveillance of kidney function widely varied from 5.5% to 100% among the <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> clinics. A younger age (p&lt;0.0001), level of lesion (p=0.001), less mobility status (p&lt;0.0001), augmentation cystoplasty (p&lt;0.0001), and <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> clinic (p&lt;0.0001) were each independently associated with surveillane of kidney function on multivariate analysis. The <abbr title="National Spina Bifida Patient Registry">NSBPR</abbr> clinic remained an indepdendent predictor for surveillance of kidney function in all sensitivity analyses, supporting a wide variation in practice.<a class="citation" href="#chu2020a"><span style="vertical-align: super">11</span></a></p>

<h2 id="multi-institutional-bladder-exstrophy-consortium">
<a class="anchor" href="#multi-institutional-bladder-exstrophy-consortium" aria-hidden="true"><span class="octicon octicon-link"></span></a>Multi-Institutional Bladder Exstrophy Consortium</h2>

<p><abbr title="Multi-Institutional Bladder Exstrophy Consortium">MIBEC</abbr> is a multicenter collaborative that was developed to increase the experience and proficiency in the care of bladder exstrophy among Boston Children’s Hospital, Children’s Hospital of Philadelphia, and Children’s Hospital of Wisconsin in 2013. Its objective is to refine the technical aspects and postoperative care for the complete primary repair of bladder exstrophy (<abbr title="complete primary repair of exstrophy">CPRE</abbr>) with the ultimate goal to decrease the complications and improve the long-term outcomes. Each center alternates as the host with observation, commentary, and critique by the visiting surgeons. High-definition video is used to record all surgeries and to facilitate a live local and distant broadcasting for real-time observation.<a class="citation" href="#borer2017a"><span style="vertical-align: super">12,13</span></a></p>

<p>Borer <em>et al</em> initially assessed the short-term outcomes in a series of 27 consecutive patients during the first 2 years of <abbr title="Multi-Institutional Bladder Exstrophy Consortium">MIBEC</abbr>. A total of 13 female and 14 males patietns underwent a <abbr title="complete primary repair of exstrophy">CPRE</abbr> at a median age of 2.3 monghts (range 0.1–51.5). No dehiscences occurred, while the complications varied between male and female patients. A total of 6 female patients developed a complication (pyelonephritis in 5, urinary retention in 4, temporary <abbr title="clean intermittent catheterization">CIC</abbr> in 2, cutaneous vesicostomy in 1, and bladder rupture in 1), while 3 male patients developed a complication (urethrocutaneous fistula in 2, pyelonephritis in 1). They observed a higher rate of bladder outlet obstruction in female patients than previously reported in the literature but a comparibly low rate of complications in male patients as well as early signs of continence and spontaneous voiding in both.<a class="citation" href="#borer2017a"><span style="vertical-align: super">12</span></a></p>

<p>Weiss <em>et al</em> also assessed the continence and dry intervals in a retrospective cohort study of 54 patients who underwent a <abbr title="complete primary repair of exstrophy">CPRE</abbr> prior to <abbr title="Multi-Institutional Bladder Exstrophy Consortium">MIBEC</abbr> between May 1993 and January 2013. A total of 35 (64.8%) patients were voiding per urethra, while 18 (33.3%) performed clean intermittent catheterization (<abbr title="clean intermittent catheterization">CIC</abbr>) and 1 underwent a cutaneous vesicostomy. Of those voiding per urethra, 25 (71.4%) patients did not require any secondary procedures for continence. A total of 26 (48.1%) patients were continent or had a dry interval of at 3 hours, including 11 (20.4%) that were truly continent with voiding per urethra. Only 9 (16.7%) patients were continent with voiding per urethra after a single surgery.<a class="citation" href="#weiss2020a"><span style="vertical-align: super">13</span></a></p>

<h2 id="urologic-management-to-preserve-initial-renal-function-protocol-for-young-children-with-spina-bifida">
<a class="anchor" href="#urologic-management-to-preserve-initial-renal-function-protocol-for-young-children-with-spina-bifida" aria-hidden="true"><span class="octicon octicon-link"></span></a>Urologic Management to Preserve Initial Renal Function Protocol for Young Children with Spina Bifida</h2>

<p><abbr title="Urologic Management to Preserve Initial Renal Function">UMPIRE</abbr> is an iterative quality improvement protocol that was developed in 2014 to optimize the urologic management of patients with <abbr title="myelomeningocele">MMC</abbr> from the newborn period to 5 years of age. Its objectives are to implement a standardized protocol for newborns with <abbr title="myelomeningocele">MMC</abbr> across multiple centers, to determine the adherence to the protocol, to determine if the proposed protocol is optimal to maximize the urologic function while minimizing morbidity, to characterize the deviations from the protocol, and to determine its longitudinal impact on bladder and renal function. The participating centers include Duke University, Ann and Robert H. Lurie Children's Hospital of Chicago, Children's Hospital of Alabama, Children's Hospital Los Angeles, Monroe Carrell Jr. Children's Hospital at Vanderbilt University, Oregon Health Sciences University, Primary Children's Hospital, Seattle Children's Hospital, and Texas Children's Hospital. The study design and protocol have been described previously.<a class="citation" href="#routh2016a"><span style="vertical-align: super">14</span></a></p>

<p>Tanaka <em>et al</em> initially assessed the baseline urinary tract imaging in a study of 193 infants with <abbr title="myelomeningocele">MMC</abbr> between 2015–2018. A majority had normal or near normal imaging characteristics, including 2 normal kidneys in 105 (55.9%) patients and <abbr title="Society of Fetal Urology">SFU</abbr> grade 1-2 hydronephrosis in at least 1 kidney in 76 (40.4%) patients on renal and bladder ultrasound, no <abbr title="vesicoureteral reflux">VUR</abbr> in 154 (84.6%) patients on cystogram, and no renal defects in 61 (92.4%) patients and a difference in the differential renal function &lt;15% in 62 (93.9%) patients on <abbr title="dimercaptosuccinic acid">DMSA</abbr> renal scan.<a class="citation" href="#tanaka2019a"><span style="vertical-align: super">15</span></a></p>

<p>Wallis <em>et al</em> also sought to assess the incidence and identify the risk factors for <abbr title="urinary tract infection">UTI</abbr> in a study of 299 infants with <abbr title="myelomeningocele">MMC</abbr> between February 2015 and August 2019. A total of 48 (16.1%) patients were treated for a <abbr title="urinary tract infection">UTI</abbr> during the first 4 months of life. However, only 12 (4.0%) met the strict definition for <abbr title="urinary tract infection">UTI</abbr> with an abnormal urinalysis (&gt;10 <abbr title="white blood cell">WBC</abbr>/<abbr title="high powered field">HPF</abbr> on urine microscopy and/or leukocyte esterase ≥2+ on dipstick), positive urine culture (≥100,000 <abbr title="colony-forming unit">CFU</abbr>/mL of 1 or 2 speciated organisms), and at least 2 symptoms. Patients with <abbr title="Society of Fetal Urology">SFU</abbr> grade 3-4 hydronephrosis had a significantly higher risk of <abbr title="urinary tract infection">UTI</abbr> compared to those with no hydronephrosis (<abbr title="relative risk">RR</abbr> 10.1, 95% <abbr title="confidence interval">CI</abbr> 2.8–36.3), and patients on <abbr title="clean intermittent catheterization">CIC</abbr> had a significantly higher risk of <abbr title="urinary tract infection">UTI</abbr> (<abbr title="relative risk">RR</abbr> 3.3, 95% <abbr title="confidence interval">CI</abbr> 1.0–10.5). Patients who received no <abbr title="continuous antibiotic prophylaxis">CAP</abbr> beyond the perioperative period also had a non-statistically significantly lower risk of <abbr title="urinary tract infection">UTI</abbr> (<abbr title="relative risk">RR</abbr> 0.5, 95% <abbr title="confidence interval">CI</abbr> 0.1–2.1) and treatment for <abbr title="urinary tract infection">UTI</abbr> (<abbr title="relative risk">RR</abbr> 0.6, 95% <abbr title="confidence interval">CI</abbr> 0.3–1.1) than those who remained on <abbr title="continuous antibiotic prophylaxis">CAP</abbr>. They concluded that the incidence of <abbr title="urinary tract infection">UTI</abbr> was low and questioned the necessity of routine <abbr title="continuous antibiotic prophylaxis">CAP</abbr> in newborns with <abbr title="myelomeningocele">MMC</abbr>.<a class="citation" href="#wallis2021a"><span style="vertical-align: super">16</span></a></p>

<p>Tanaka <em>et al</em> most recently assessed the baseline urodynamic findings at or before 3 months of age in a study of 157 patients with <abbr title="myelomeningocele">MMC</abbr> between May 2015 to September 2017. There was a concurrence of only 50% for categorization of bladder hostility on primary review, which ultimately reached 100% with further standardization of interpretation. The categorization system was revised to group the “normal” and “safe” categories together as “low risk” as well as to exclude the diagnosis of detrusor-sphincter dyssynergia from the high-risk category due to unreliable measurement with surface patch electrodes. The final categorizations were low risk in 38 (24%) patients, intermediate risk in 96 (61%) patients, and high risk in 23 (15%) patients.<a class="citation" href="#tanaka2021a"><span style="vertical-align: super">17</span></a></p>

<h2 id="pediatric-urology-robotic-surgery">
<a class="anchor" href="#pediatric-urology-robotic-surgery" aria-hidden="true"><span class="octicon octicon-link"></span></a>Pediatric Urology Robotic Surgery</h2>

<p>The <abbr title="Pediatric Urology Robotic Surgery">PURS</abbr> consortium is a multicenter collaborative that was developed at University of Chicago in 2015. Its objective is to assess the safety, feasibility, and efficacy of robot-assisted laparoscopic surgery as a comparable option to traditional open surgery in the pediatric population. The participating centers have varied over time and currently include University of Chicago, Children’s Healthcare of Atlanta, Children’s Hospital of Philadelphia, Cincinnati Children’s Hospital Medical Center, Riley Hospital of Children at Indiana University Health, Seattle Children’s Hospital, Texas Children’s Hospital, and Weill Cornell Medical College.</p>

<p>Avery <em>et al</em> initially assessed the outcomes and complications of robot-assisted laparoscopic pyeloplasty in a retrospective cohort study of 60 infants between April 2006 and July 2012. A total of 54 (92%) patients had an improved or resolved hydronephrosis, while 2 patients required additional surgery due to a recurrent obstruction. A total of 7 (11%) patients developed a complication. The mean operative time was 3 hours and 52 minutes (<abbr title="standard deviation">SD</abbr> ±43 minutes). They concluded that the success and complication rates favorably compared with contemporary series of open and laparoscopic pyeloplasty in infants.<a class="citation" href="#avery2015a"><span style="vertical-align: super">18</span></a></p>

<p>The <abbr title="Pediatric Urology Robotic Surgery">PURS</abbr> consortium has assessed the outcomes and complications of robot-assisted laparoscopic extravesical ureteral reimplantation as well. Boysen <em>et al</em> conducted a retrospective cohort study of 260 patients (363 ureters) between 2005-2014. The cohort included 90 patients with complex anatomy, including 42 patients with a duplicated collecting system, 40 patients with a failed endoscopic Deflux injection, and 8 patients with a periureteral diverticulum. Of 280 ureters with a postoperative cystogram, 246 (87.9%) had a radiographic success. A total of 25 (9.6%) patients developed a complication, including 7 Clavien-Dindo grade 3 and no grade 4-5 complications. Four (3.9%) patients developed a transient urinary retention after a bilateral surgery.<a class="citation" href="#boysen2017a"><span style="vertical-align: super">19</span></a> Boysen <em>et al</em> subsequently conducted a prospective cohort study of 143 patients (199 ureters) between 2015-2017. The cohort included a grade III-V <abbr title="vesicoureteral reflux">VUR</abbr> in 146 (73.4%) and complex anatomy in 59 (29.7%) ureters. Of 145 ureters with a postoperative cystogram, 136 (93.8%) had a radiographic success, including 97 (94.1%) with grade III-V <abbr title="vesicoureteral reflux">VUR</abbr>. A total of 16 (11.2%) patients developed a complication, including 8 Clavien-Dindo grade 3 and no grade 4-5 complications. Four (7.1%) patients developed a transient urinary retention after a bilateral surgery. The mean operative time was 194 minutes (<abbr title="standard deviation">SD</abbr> ±62 minutes). They concluded that the success and complication rates favorably compared with contemporary series of open ureteral reimplantation.<a class="citation" href="#boysen2018a"><span style="vertical-align: super">20</span></a></p>

<p>The <abbr title="Pediatric Urology Robotic Surgery">PURS</abbr> consortium has also published on 90-day complications of robot-assisted laparoscopic surgery, outcomes and complications of robot-assisted laparoscopic Mitrofanoff appendicovesicstomy, and outcomes and complications of robot-assisted laparoscopic ureterocalicostomy.<a class="citation" href="#dangle2016a"><span style="vertical-align: super">21,22,23</span></a></p>

<h2 id="pediatric-urologists-researching-surgical-outcomes-using-health-information-technology">
<a class="anchor" href="#pediatric-urologists-researching-surgical-outcomes-using-health-information-technology" aria-hidden="true"><span class="octicon octicon-link"></span></a>Pediatric Urologists Researching Surgical Outcomes Using Health Information Technology</h2>

<p>The <abbr title="Pediatric Urologists Researching Surgical Outcomes Using Health Information Technology">PURSUIT</abbr> network is a multicenter colloaborative that was developed at Children’s Hospital Colorado in 2016. Its objective is to study the clinical outcomes and to define the best practices for management of patients with congenital anomalies of the kidney and urinary tract (<abbr title="congenital anomalies of the kidney and urinary tract">CAKUT</abbr>) through a prospective data collection using tools in the electronic health record (<abbr title="electronic health record">EHR</abbr>). The participating centers include Children’s Hospital Colorado, Rady Children’s Hospital San Diego, Texas Children’s Hospital, University of Virginia Children’s Hospital, and Yale New Haven Children’s Hospital.</p>

<p>Vemulakonda <em>et al</em> initially sought to identify the clinical and demographic factors associated with infant pyeloplasty in a prospective cohort study of 197 infants &lt;6 months of age with <abbr title="Society of Fetal Urology">SFU</abbr> grade 3-4 hydronephrosis between 2/1/2018 to 9/30/2019. They noted a significant variability in the rate of infant pyeloplasty among the participating centers as well as a similar rate of improved hydronephrosis over time for patients who were observed and underwent pyeloplasty. These findings suggested the need to standardize the evaluation and indications for pyeloplasty in infants with suspected ureteropelvic junction obstruction.<a class="citation" href="#vemulakonda2021a"><span style="vertical-align: super">24</span></a></p>

<p>Vemulakonda <em>et al</em> also assessed the feasibility of a standarized template for clinic visits in patients with congenital hydronephrosis and/or <abbr title="vesicoureteral reflux">VUR</abbr>. In a random sample of 230 infants between 1/1/2020 and 4/30/2021, they noted a high amount of agreement (&gt;85%) between manual chart review and data extracted from the <abbr title="electronic health record">EHR</abbr>.<a class="citation" href="#vemulakonda2022a"><span style="vertical-align: super">25</span></a></p>

<h2 id="pediatric-urology-midwest-alliance">
<a class="anchor" href="#pediatric-urology-midwest-alliance" aria-hidden="true"><span class="octicon octicon-link"></span></a>Pediatric Urology Midwest Alliance</h2>

<p><abbr title="Pediatric Urology Midwest Alliance">PUMA</abbr> is a regional multicenter collaborative that was developed among Ann &amp; Robert H. Lurie Children’s Hospital of Chicago, Cincinnati Children’s Hospital Medical Center, Mayo Clinic, Nationwide Children’s Hospital, and Riley Hospital for Children at Indiana University Health in 2017.</p>

<p>To determine the feasiblity of this collaborative, Szymanski <em>et al</em> initially assessed the probability of augemtation cystoplatsy or urinary diversion and <abbr title="clean intermittent catheterization">CIC</abbr> in a retrospective cohort study of 216 patients with classic bladder exstorphy between 1980 and 2016. They specifically focused on these outcomes due to their clinical relevance and reliable documentation in the medical records and performed a suvival analysis to account for the lost to follow-up and varying ages of patients. Of 212 patients who underwent a primary closure, 108 (50.9%) patients underwent an augmentation cystoplasty and 10 (4.7%) patients underwent a urinary diversion. <abbr title="clean intermittent catheterization">CIC</abbr> was performed in 143 patients (67.4%) at the last follow-up, including 65 (85.5%) adults without a urinary divesion. The probability of augmetnation cystoplasty or urinary diversion was 14.9% by 5 years of age, 50.7% by 10 years of age, and 70.1% by 18 years of age on survival analysis. Furthermore, the probability of augmentation cystoplasty or urinary divesion was 60.7% at 10 years after a bladder neck procedure on surviavl analysis. They concluded that these outcomes were much more common than previously reported in the literature.<a class="citation" href="#szymanski2019a"><span style="vertical-align: super">26</span></a></p>

<p>Using a similar approach, McLeod <em>et al</em> then assessed the risk of renal replacement therapy (<abbr title="renal replacement therapy">RRT</abbr>) and <abbr title="clean intermittent catheterization">CIC</abbr> in a retrospective cohort study of 274 patients with posterior urethral valves (<abbr title="posterior urethral valve">PUV</abbr>) who were treated withint 90 days of life between 1995 and 2005. A total of 42 (15.3%) patients progressed to dialysis or renal transplantation. The nadir serum creatinine in the first year of life was the only independent predictor of <abbr title="renal replacement therapy">RRT</abbr> on multivariate analysis. After stratification by the nadir serum creatinine, the risk of <abbr title="renal replacement therapy">RRT</abbr> by 10 years was 0% for &lt;0.4 mg/dL, 2% for 0.4-0.69 mg/dL, 27% for 0.7-0.99 mg/dL, and 100% for ≥1.0 mg/dL on surviavl analysis. <abbr title="clean intermittent catheterization">CIC</abbr> was also recommended in 60 (21.9%) patients in follow-up. The risk of <abbr title="clean intermittent catheterization">CIC</abbr> was 10% by 10 years of age and 50% by 14 years of age on survival analysis. A younger birth cohort from 2005-2015 (<abbr title="hazard ratio">HR</abbr> 15.3, 95% <abbr title="confidence interval">CI</abbr> 4.6-51.1), nadir serum creatnine ≥1.0 mg/dL (<abbr title="hazard ratio">HR</abbr> 8.3, 95% <abbr title="confidence interval">CI</abbr> 3.6-19.2), and anticholinergic use (<abbr title="hazard ratio">HR</abbr> 6.8, 95% <abbr title="confidence interval">CI</abbr> 2.7-17.2) were each independently associated with risk of <abbr title="clean intermittent catheterization">CIC</abbr> on multivariant analysis. They concluded that the risk of <abbr title="renal replacement therapy">RRT</abbr> and <abbr title="clean intermittent catheterization">CIC</abbr> increased with age and that the nadir serum creatinine strongly predicted the need for <abbr title="renal replacement therapy">RRT</abbr> in the first year of life.<a class="citation" href="#mcleod2019a"><span style="vertical-align: super">27</span></a></p>

<p>Fuchs <em>et al</em> most recently assessed the long-term urinary and bowel management in a cross-sectional study of 160 patients with cloacal exstrophy or covered variants. A majority of patients were managed with <abbr title="clean intermittent catheterization">CIC</abbr> or incontinent urinary diversion. <abbr title="clean intermittent catheterization">CIC</abbr> was performed in 29 (83%) patients between 10-18 years of age and 46 (68%) adults, while an incontinent diversion was performed in 3 (9%) patients between 10-18 years of age and 19 (28%) adults. Only 14 (14%) patient were either catheterized or leaking per urethra, while no patients were voiding per urethra with a normal detrusor contraction and intact urinary spihncter. There was no significant difference in the age-adjusted odds of an incontinent urinary diversion among the participating centers or over time. A majority of patients were also managed with an intestinal diversion. An intestinal diversion was performed in 126 (79%) patients, while a pull-through was performed in the remaining 34 (21%) patients in addition to a Malone anterograde continence enama in 16 of these patients. The probability of an intestinal diversion varied significantly among the participating centers with a range of 55-91% but did not significantly change over time. Based on these unpromising results, they questioned the functional goals of pateitns with cloacal exstrophy and suggested that the reconstrucive surgeries by individualized accordingly.<a class="citation" href="#fuchs2023a"><span style="vertical-align: super">28</span></a></p>

<p>In concert with these efforts, <abbr title="Pediatric Urology Midwest Alliance">PUMA</abbr> has begun to study their patients with bladder exstrophy and <abbr title="posterior urethral valve">PUV</abbr> in a prospective fashion. They noted a significant variation in the management and outcomes of patients with <abbr title="posterior urethral valve">PUV</abbr> among the participating centers.<a class="citation" href="#mcleod2018a"><span style="vertical-align: super">29,30</span></a> They therefore developed a standardized clinical assessment and management plan by conducting a survey of pediatric urologists at the participating centers on their general practices and reviewing the available evidence.<a class="citation" href="#mcleod-a"><span style="vertical-align: super">30</span></a> Selected surgeons also began to travel and observe the bladder exstrophy closures among the participating centers with the goal to refine the technical aspects of surgery and to promote an ongoing teaching, surgical coahing, and expertise. Kaefer <em>et al</em> described the use of intraoperative laser angiography to assess the real-time penile perfusion during various stages of closure.<a class="citation" href="#kaefer2022a"><span style="vertical-align: super">31</span></a></p>

<h2 id="prevention-of-urinary-stones-with-hydration-push-trial">
<a class="anchor" href="#prevention-of-urinary-stones-with-hydration-push-trial" aria-hidden="true"><span class="octicon octicon-link"></span></a>Prevention of Urinary Stones with Hydration (<abbr title="Prevention of Urinary Stones with Hydration">PUSH</abbr>) Trial</h2>

<p>The <abbr title="Prevention of Urinary Stones with Hydration">PUSH</abbr> trial is a multicenter <abbr title="randomized controlled trial">RCT</abbr> (NCT03244189) on the use of behavioral interventions to increase and maintain a higher fluid intake for prevention of stones. The participating centers are in the Urinary Stone Disease Research Network, including Duke University (sponsor), Children’s Health Texas, Children’s Hospital of Philadelphia, Cleveland Clinic, Mayo Clinic, University of Pennsylvania, University of Texas Southwestern Medical Center, University of Washington, and Washington University in St. Louis. The study design and rationale as well as the challenges encountered during the COVID-19 pandemic have been described previously.<a class="citation" href="#cd2021a"><span style="vertical-align: super">32,33</span></a></p>

<p>The study has completed its enrollment of 1,658 patients and is scheduled to conclude in May 2024. Pediatric and adult patients ≥12 years of age were included with at least 1 symptomatic stone event within 3 years prior to enrollment or within 5 years if a new stone was detected on imaging. They also had a low 24-hour urine volume (defined as less than 2 L per day for patients ≥18 years of age and &lt;25 mL/kg/day for patients &lt;18 years of age). Patients were randomized in a parallel fashion to either an intervention or control arm. All patients received a smart water bottle to self monitor their fluid intake. Those in the intervention arm also underwent 3 behavioral interventions, including a fluid prescription for the additional water they must consume each day, randomly dispersed financial incentive when they reach their daily intake goal, and coaches to assist with overcoming their personal barriers to follow the fluid prescription. The primary outcomes include a stone passage and procedural intervention for a symptomatic or asymptomatic stone; while the secondary outcomes include the formation of new asymptomatic stone, growth of existing stone by &gt;2 mm, 24-hour urine volumes, and cost of procedural interventions.<a class="citation" href="#cd2021a"><span style="vertical-align: super">32</span></a></p>

<h2 id="pediatric-urology-recovery-after-surgery-endeavor">
<a class="anchor" href="#pediatric-urology-recovery-after-surgery-endeavor" aria-hidden="true"><span class="octicon octicon-link"></span></a>Pediatric Urology Recovery after SUrgery Endeavor</h2>

<p><abbr title="Pediatric Urology Recovery after SUrgery Endeavor">PURSUE</abbr> is a prospective, multicenter study (NCT03245242) on Enhanced Recovery After Surgery (<abbr title="enhanced recovery after surgery">ERAS</abbr>) for lower urinary tract reconstruction with a possible bowel anastomosis in patients between 4–25 years of age. The participating centers include Ann &amp; Robert H. Lurie Children’s Hospital of Chicago, Children’s Health Texas, Children’s Hospital Colorado, Children’s Hospital of Pittsburgh at University of Pittsburgh Medical Center, Children’s Hospital of Richmond at Virginia Commonwealth University, Cincinnati Children’s Hospital Medical Center, Oklahoma Children’s Hospital at Oklahoma University Health, Seattle Children’s Hospital, and St. Louis Children’s Hospital. The study design and <abbr title="enhanced recovery after surgery">ERAS</abbr> protocol have been described previously.<a class="citation" href="#rove2020a"><span style="vertical-align: super">34</span></a></p>

<p>The study has both a pilot and exploratory phase. The pilot phase is designed to assess the success with and barriers to implementation of <abbr title="enhanced recovery after surgery">ERAS</abbr> in the first 5 patients at each center. The primary outcome is the protocol adherence with the goal of achieving a median of ≥70% protocol adherence per patient at ≥75% centers, while the secondary outcomes include the enrollment of ≥2 patients in the first 6 months of enrollment (to ensure a minimum level of experience with the <abbr title="enhanced recovery after surgery">ERAS</abbr> protocol) and completion of 90 days of follow-up for the first 5 patients. For the exploratory phase, the enrolled patients will be propensity matched to historical controls in the 5 years prior to implementation of <abbr title="enhanced recovery after surgery">ERAS</abbr> for comparison of outcomes. The primary outcome is the protocol adherence; while the secondary outcomes include the length of stay, emergency room visits, readmissions, reoperations, complications, pain scores, opioid usage, and differences in Quality of Recovery 9 scores.<a class="citation" href="#rove2020a"><span style="vertical-align: super">34</span></a></p>

<p>Moore <em>et al</em> most recently assessed the use of regional anesthesia in a subset of 158 patients with <abbr title="myelomeningocele">MMC</abbr> who underwent a lower urinary tract reconstruction using an <abbr title="enhanced recovery after surgery">ERAS</abbr> protocol between 2009 to 2021. Anesthesia setup significantly increased from a median 40 minutes (<abbr title="interquartile range">IQR</abbr> 34-51) for patients who did not receive any regional anesthesia to 64 minutes (<abbr title="interquartile range">IQR</abbr> 40-97) for patients who underwent the placement of regional catheters (p&lt;0.01). However, the patients who underwent the placement of regional catheters had a significantly lower median intraoperative opioid use (0.24 vs 0.80 mg/kg morphine equivalents, p&lt;0.01) and lower in-hospital postoperative opioid use (0.05 vs 0.23 mg/kg/day morphine equivalents, p&lt;0.01) with no difference in pain scores. They concluded that patients with <abbr title="myelomeningocele">MMC</abbr> benefited from regional anesthesia, despite the false perception of less postoperative pain due to their sensory deficits.<a class="citation" href="#moore2023a"><span style="vertical-align: super">35</span></a></p>

<h2 id="gonadoblastoma-and-invasive-germ-cell-tumors">
<a class="anchor" href="#gonadoblastoma-and-invasive-germ-cell-tumors" aria-hidden="true"><span class="octicon octicon-link"></span></a>Gonadoblastoma and Invasive Germ Cell Tumors</h2>

<p>The registry is one of 2 open studies that are a part of the Pediatric Urology Working Group. Its objective is to assess the incidence of gonadoblastoma and <abbr title="germ cell tumors">GCTs</abbr> in patients with <abbr title="differences of sexual development">DSD</abbr> who underwent gonadectomy and to understand the oncologic outcomes for patients who developed a pre-malignant or malignant tumor. The study is actively recruiting participating centers and currently includes University of Kentucky, Children’s Hospital Colorado, and Children’s Hospital &amp; Medical Center Nebraska.</p>

<h2 id="pediatric-kidney-stone-care-improvement-network">
<a class="anchor" href="#pediatric-kidney-stone-care-improvement-network" aria-hidden="true"><span class="octicon octicon-link"></span></a>Pediatric KIDney Stone Care Improvement Network</h2>

<p><abbr title="Pediatric KIDney Stone Care Improvement Network">PKIDS</abbr> is a care improvement network comprised of 26 pediatric healthcare systems. The network is conducting a prospective cohort study (NCT04285658) on the effectiveness of ureteroscopy, shockwave lithotripsy, and percutaneous nephrolithotomy for kidney and/or ureteral stones in patients between 8–21 years of age. Its objective is to improve the selection of surgical treatment options by incorporating patient-specific factors and outcomes. The excecutive committee includes Children’s Hospital of Philadelphia (sponsor), Children’s Hospital of Wisconsin, Cincinnati Children’s Hospital Medical Center, Boston Children’s Hospital, Ann &amp; Robert H. Lurie Children’s Hospital of Chicago, and University of Pennsylania. The conceptual framework and protocol have been described previously.^37.38^</p>

<p>Its enrollment began in February 2020 and is estimated to be completed in January 2024 with the goal of enrolling 1,290 patients. The primary outcome is the stone clearance (defined as absence of residual calculus &gt;4 mm on postoperative ultrasound); while the secondary outcomes include several patient-experience outcomes (patient-reported physical, emotional, and social health outcomes), analgesic use, and use of healthcare resources.<a class="citation" href="#ellison2022a"><span style="vertical-align: super">36</span></a></p>

<h2 id="western-pediatric-urology-consortium">
<a class="anchor" href="#western-pediatric-urology-consortium" aria-hidden="true"><span class="octicon octicon-link"></span></a>Western Pediatric Urology Consortium</h2>

<p><abbr title="Western Pediatric Urology Consortium">WPUC</abbr> is a regional multicenter collaborative that was developed at Children’s Hospital of Orange County in 2020. There are a total of 19 participating centers, including 3 in Canada, 2 in the eastern <abbr title="United States">US</abbr>, and the remaining in the western <abbr title="United States">US</abbr>.</p>

<p>Holzman <em>et al</em> initially assessed the impact of the COVID-19 pandemic on the presentation and management of acute testicular torsion in a study of 221 patients between 2 months and 18 years of age. The median time from the onset of symptoms to presentation significantly increased from 7.5 hours (<abbr title="interquartile range">IQR</abbr> 4.0–28.0) in the 14 months prior to the COVID-19 pandemic to 17.9 hours (<abbr title="interquartile range">IQR</abbr> 5.5–48.0) during the COVID-19 pandemic (p=0.04). The rate of orchiectomy had a corresponding increase from 40 (29%) patients to 34 (43%) patients, respectively (p=0.06).<a class="citation" href="#holzman2021b"><span style="vertical-align: super">37</span></a></p>

<p>Yamashiro <em>et al</em> also sought to develop a surgical atlas of techniques for hypospadias repair by assessing the surgical volume and methods for recording operatve notes as well as the technical details for tubularized incised plate distal and proximal hypospadias repairs. A total of 24 (96.0%) surgeons at 12 centers recorded their operative notes in an <abbr title="electronic health record">EHR</abbr>, of which 16 (66.7%) edited an existing template. They noted a significant variability with the use of surgeon-specific modifications for these 2 types of repairs.<a class="citation" href="#yamashiro2023a"><span style="vertical-align: super">38</span></a></p>

<h2 id="traumatic-renal-injury-collaboration-for-kids">
<a class="anchor" href="#traumatic-renal-injury-collaboration-for-kids" aria-hidden="true"><span class="octicon octicon-link"></span></a>Traumatic Renal Injury Collaboration for Kids</h2>

<p><abbr title="Traumatic Renal Injury Collaboration for Kids">TRICK</abbr> is a multicenter collaborative that was developed for pediatric renal trauma in 2021. <abbr title="Traumatic Renal Injury Collaboration for Kids">TRICK</abbr> has presented at several national meetings but not published to date.</p>

<p>Lucas <em>et al</em> initially assessed the follow-up and recommentations for restriction of physical activity in a retrospective cohort study of 328 patients &lt;18 years of age with grades III-V renal trauma at 5 level-1 pediatric trauma centers between 2007–2020. Follow-up occurred at a median of 30.0 days (<abbr title="interquartile range">IQR</abbr> 11.0–56.0) after discharge with trauma surgery in 110 (33.5%) patients, with urology in 103 (31.4%) patients, and with nephrology in 15 (4.6%) patients. Only 184 (56.1%) patients received any recommendations for return to physical activity, which widely varied in the type of restriction and duration with a median of 5.0 weeks (<abbr title="interquartile range">IQR</abbr> 2.0–6.0). These findings suggested the need to standardize the follow-up and recommendations for restriciton of physical activty after high-grade renal trauma.<a class="citation" href="#lucas2021a"><span style="vertical-align: super">39</span></a></p>

<p>In a subsequent retrospective cohort study of 345 patients &lt;18 years of age with high-grade renal trauma over the same period, Lee <em>et al</em> assessed the impact of race and insurance status on their presentation, management, and outcomes. Caucasian patients presented at a signicantly older age than African American patients and those with other races (p=0.001) and with a significantly lower rate of penetrating trauma than African American patients (p=0.002), but there was no differences in the rates of surgery, admission to the intensive care unit, complications, or mortality. Patients with public insurance also had a significantly higher injury severity score (p=0.02) and rate of blood transfusion (p=0.03) than those with private insurance, but there was again no differences in the rates of surgery, admission to the intensive care unit, complications, and mortality.<a class="citation" href="#lee2021a"><span style="vertical-align: super">40</span></a></p>

<p>Tong <em>et al</em> also assessed the utility of excretory-phase computerized tomagraphy (<abbr title="excretory-phase computerized tomagraphy">EPCT</abbr>) in a retrospective cohort study of 343 patietns &lt;18 years of age with high-grade renal trauma during the same period. Patients who underwent an <abbr title="excretory-phase computerized tomagraphy">EPCT</abbr> were significantly more likely to undergo the placement of ureteral stent than those who underwent a non-<abbr title="excretory-phase computerized tomagraphy">EPCT</abbr> (p=0.009), but there was no difference in the length of hospitalization or the rates of delayed imaging, delayed surgical or radiologic intervention, complications, readmissions, or mortality. These findings questioned the utility of <abbr title="excretory-phase computerized tomagraphy">EPCT</abbr> for high-grade renal trauma and suggested the need for additional research to identify those who may benefit from multi-phase <abbr title="computed tomography">CT</abbr>.<a class="citation" href="#tong2022a"><span style="vertical-align: super">41</span></a></p>

<p>Flores <em>et al</em> most recently assessed the utility of repeat <abbr title="computed tomography">CT</abbr> in a retrospective cohort study of 84 patients &lt;18 years of age with isolated grade IV-V renal trauma between 2007–2022. There was no difference in the rates of delayed surgical or radiologic intervention, complications, readmissions, or mortaility in patients who underwent a repeat <abbr title="computed tomography">CT</abbr> and those who underwent no imaging or only a renal ultrasound. These findings questioend the utility of repeat <abbr title="computed tomography">CT</abbr> for high-grade renal trauma and suggested the need for pediatric-specific guidelines.<a class="citation" href="#flores2022a"><span style="vertical-align: super">42</span></a></p>

<p><strong id="table-1" class="table-number">Table 1</strong> Summary of Multicenter Collaboratives in Pediatric Urology**</p>

<table>
  <thead>
    <tr>
      <th style="text-align: center">Name</th>
      <th style="text-align: center">Topic</th>
      <th style="text-align: center">Date of Origin or First Publication</th>
      <th style="text-align: center">Principal Investigator(s)</th>
      <th style="text-align: center">Website</th>
    </tr>
  </thead>
  <tbody>
    <tr>
      <td style="text-align: center">Gonadoblastoma and invasive <abbr title="germ cell tumor">GCT</abbr> in <abbr title="differences of sexual development">DSD</abbr>
</td>
      <td style="text-align: center">
<abbr title="germ cell tumor">GCT</abbr> in <abbr title="differences of sexual development">DSD</abbr>
</td>
      <td style="text-align: center">2017</td>
      <td style="text-align: center">Amanda F. Saltzman and Nicholas G. Cost</td>
      <td style="text-align: center">https://puowg.spuonline.org/studies</td>
    </tr>
    <tr>
      <td style="text-align: center"><abbr title="Multi-Institutional Bladder Exstrophy Consortium">MIBEC</abbr></td>
      <td style="text-align: center">
<abbr title="complete primary repair of exstrophy">CPRE</abbr> for bladder exstrophy</td>
      <td style="text-align: center">2013</td>
      <td style="text-align: center">Center specific</td>
      <td style="text-align: center"> </td>
    </tr>
    <tr>
      <td style="text-align: center"><abbr title="National Spina Bifida Patient Registry">NSBPR</abbr></td>
      <td style="text-align: center">Spina bifida</td>
      <td style="text-align: center">2008</td>
      <td style="text-align: center">Center specific</td>
      <td style="text-align: center">https://www.cdc.gov/ncbddd/spinabifida/nsbprregistry.html</td>
    </tr>
    <tr>
      <td style="text-align: center">
<abbr title="Pediatric KIDney Stone Care Improvement Network">PKIDS</abbr> Network</td>
      <td style="text-align: center">Surgical management of urolithiasis</td>
      <td style="text-align: center">2020</td>
      <td style="text-align: center">Gregory E. Tasian</td>
      <td style="text-align: center">https://clinicaltrials.gov/ct2/show/NCT04285658</td>
    </tr>
    <tr>
      <td style="text-align: center"><abbr title="Pediatric Urology Midwest Alliance">PUMA</abbr></td>
      <td style="text-align: center">Varied</td>
      <td style="text-align: center">2017</td>
      <td style="text-align: center">Study specific</td>
      <td style="text-align: center">https://pumadocs.org/</td>
    </tr>
    <tr>
      <td style="text-align: center">
<abbr title="Pediatric Urology Robotic Surgery">PURS</abbr> Consortium</td>
      <td style="text-align: center">Robot-assisted laparoscopic surgery</td>
      <td style="text-align: center">2015</td>
      <td style="text-align: center">Mohan S. Gundeti</td>
      <td style="text-align: center"> </td>
    </tr>
    <tr>
      <td style="text-align: center"><abbr title="Pediatric Urology Recovery after SUrgery Endeavor">PURSUE</abbr></td>
      <td style="text-align: center">
<abbr title="enhanced recovery after surgery">ERAS</abbr> for lower urinary tract reconstruction</td>
      <td style="text-align: center">2017</td>
      <td style="text-align: center">Kyle O. Rove</td>
      <td style="text-align: center">https://clinicaltrials.gov/ct2/show/NCT03245242</td>
    </tr>
    <tr>
      <td style="text-align: center">
<abbr title="Pediatric Urologists Researching Surgical Outcomes Using Health Information Technology">PURSUIT</abbr> Network</td>
      <td style="text-align: center"><abbr title="congenital anomalies of the kidney and urinary tract">CAKUT</abbr></td>
      <td style="text-align: center">2016</td>
      <td style="text-align: center">Vijaya M. Vemulakonda</td>
      <td style="text-align: center"> </td>
    </tr>
    <tr>
      <td style="text-align: center">
<abbr title="Prevention of Urinary Stones with Hydration">PUSH</abbr> Trial</td>
      <td style="text-align: center">Fluid intake for urolithiasis</td>
      <td style="text-align: center">2017</td>
      <td style="text-align: center">Charles D. Scales</td>
      <td style="text-align: center">https://clinicaltrials.gov/ct2/show/NCT03244189</td>
    </tr>
    <tr>
      <td style="text-align: center">
<abbr title="Society of Fetal Urology">SFU</abbr> Hydronephrosis Registry</td>
      <td style="text-align: center">Prenatal hydronephrosis</td>
      <td style="text-align: center">2006</td>
      <td style="text-align: center">C.D. Anthony Herndon</td>
      <td style="text-align: center"> </td>
    </tr>
    <tr>
      <td style="text-align: center"><abbr title="Traumatic Renal Injury Collaboration for Kids">TRICK</abbr></td>
      <td style="text-align: center">Renal trauma</td>
      <td style="text-align: center">2021</td>
      <td style="text-align: center">Center specific</td>
      <td style="text-align: center"> </td>
    </tr>
    <tr>
      <td style="text-align: center"><abbr title="Urologic Management to Preserve Initial Renal Function">UMPIRE</abbr></td>
      <td style="text-align: center">Protocol for urologic management of spina bifida</td>
      <td style="text-align: center">2014</td>
      <td style="text-align: center">Center specific</td>
      <td style="text-align: center">https://www.cdc.gov/ncbddd/spinabifida/umpire.html</td>
    </tr>
    <tr>
      <td style="text-align: center"><abbr title="Western Pediatric Urology Consortium">WPUC</abbr></td>
      <td style="text-align: center">Varied</td>
      <td style="text-align: center">2020</td>
      <td style="text-align: center">Anthony E, Khoury</td>
      <td style="text-align: center"> </td>
    </tr>
  </tbody>
</table>

<h2 id="conclusion">
<a class="anchor" href="#conclusion" aria-hidden="true"><span class="octicon octicon-link"></span></a>Conclusion</h2>

<p>Many multicenter collaboratives have recently developed in the <abbr title="United States">US</abbr> on a wide variety of topics in pediatric urology. They have generally been of higher quality with a majority having a large sample size and prospective study design. These types of multicenter collaboratives are critical to advancing the field of pediatric urology.</p>

<h2 class="key-points-head" id="key-points">
<a class="anchor" href="#key-points" aria-hidden="true"><span class="octicon octicon-link"></span></a>Key Points</h2>

<ul class="key-points-list">
  <li>The quality of research in pediatric urology is historically low due to a predominance of small retrospective studies at single centers.</li>
  <li>A multicenter collaboration has a multitude of advantages, including a larger sample size to increase the statistical power (which is particularly important for rare and complex conditions), more generalizability, more evenly distributed workload for research, educational and funding opportunities, building a relationship with the participating centers, and building an area of expertise.</li>
  <li>Many multicenter collaboratives have recently developed in the <abbr title="United States">US</abbr> with a higher-quality study design on a wide variety of topics in pediatric urology.</li>
</ul>

<h2 id="references">
<a class="anchor" href="#references" aria-hidden="true"><span class="octicon octicon-link"></span></a>References</h2>

<ol class="bibliography">
<li>
<span id="zee2016a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Zee RS, Herbst KW, Kim C, McKenna PH, Bentley T, Cooper CS, <i>et al.</i></b></span>. <span style="font-variant: normal">Commentary to ‘Urinary tract infections in children with prenatal hydronephrosis: A risk assessment from the Society for Fetal Urology Hydronephrosis Registry.’</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2016; <b>12</b> (4)</span>: <span style="text-decoration: none">262–263</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2016.05.033</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/27290614/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2016.05.033" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="zee2017a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Zee RS, Herndon CDA, Cooper CS, Kim C, McKenna PH, Khoury A, <i>et al.</i></b></span>. <span style="font-variant: normal">Time to resolution: A prospective evaluation from the Society for Fetal Urology hydronephrosis registry</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2017; <b>13</b> (3)</span>: <span style="text-decoration: none">316.e1–316.e5</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2016.12.012</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/28215834/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2016.12.012" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="holzman2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Holzman SA, Braga LH, Zee RS, Herndon CDA, Davis-Dao CA, Kern NG, <i>et al.</i></b></span>. <span style="font-variant: normal">Correspondence to the article ‘risk of urinary tract infection in patients with hydroureter: an analysis from the society of fetal urology prenatal hydronephrosis registry.’</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2021; <b>18</b> (5)</span>: <span style="text-decoration: none">722–723</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2022.07.031</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/34556410/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2022.07.031" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="chamberlin2022a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Chamberlin JD, Braga LH, Davis-Dao CA, Herndon CDA, Holzman SA, Herbst KW, <i>et al.</i></b></span>. <span style="font-variant: normal">Continuous antibiotic prophylaxis in isolated prenatal hydronephrosis</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2022; <b>18</b> (3)</span>: <span style="text-decoration: none">363.e1–363.e7</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2022.03.027</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/35525823/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2022.03.027" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="routh2017a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Routh JC, Joseph DB, Liu T, Schechter MS, Thibadeau JK, Chad Wallis M, <i>et al.</i></b></span>. <span style="font-variant: normal">Variation in surgical management of neurogenic bowel among centers participating in National Spina Bifida Patient Registry</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Rehabil Med</i></span> <span style="text-decoration: none">2017; <b>10</b> (3-4)</span>: <span style="text-decoration: none">303–312</span>. <span style="text-decoration: underline">DOI: 10.3233/prm-170460</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/29125521/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3233/prm-170460" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="routh2018a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Routh JC, Joseph DB, Liu T, Schechter MS, Thibadeau JK, Wallis MC, <i>et al.</i></b></span>. <span style="font-variant: normal">Bladder Reconstruction Rates Differ among Centers Participating in National Spina Bifida Patient Registry</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2018; <b>199</b> (1)</span>: <span style="text-decoration: none">268–273</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2017.08.084</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/28830753/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2017.08.084" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="freeman2017a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Freeman KA, Castillo H, Castillo J, Liu T, Schechter M, Wiener JS, <i>et al.</i></b></span>. <span style="font-variant: normal">Faculty Opinions recommendation of Variation in bowel and bladder continence across US spina bifida programs: A descriptive study.</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature</i></span> <span style="text-decoration: none">2017; <b>10</b> (3-4)</span>: <span style="text-decoration: none">231–241</span>. <span style="text-decoration: underline">DOI: 10.3410/f.732730097.793549032</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/29125511/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3410/f.732730097.793549032" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="liu2018a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Liu T, Ouyang L, Thibadeau J, Wiener JS, Routh JC, Castillo H, <i>et al.</i></b></span>. <span style="font-variant: normal">Longitudinal Study of Bladder Continence in Patients with Spina Bifida in the National Spina Bifida Patient Registry</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2018; <b>199</b> (3)</span>: <span style="text-decoration: none">837–843</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2017.11.048</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/29132982/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2017.11.048" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="smith2019a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Smith KA, Liu T, Freeman KA, Betz C, Clayton GH, Castillo H, <i>et al.</i></b></span>. <span style="font-variant: normal">Differences in continence rates in individuals with spina bifida based on ethnicity</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Rehabil Med</i></span> <span style="text-decoration: none">2019; <b>12</b> (4)</span>: <span style="text-decoration: none">361–368</span>. <span style="text-decoration: underline">DOI: 10.3233/prm-180556</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/31744028/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3233/prm-180556" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="wiener2017a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Wiener JS, Suson KD, Castillo J, Routh JC, Tanaka S, Liu T, <i>et al.</i></b></span>. <span style="font-variant: normal">Bowel management and continence in adults with spina bifida: Results from the National Spina Bifida Patient Registry 2009–15</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Rehabil Med</i></span> <span style="text-decoration: none">2017; <b>10</b> (3-4)</span>: <span style="text-decoration: none">335–343</span>. <span style="text-decoration: underline">DOI: 10.3233/prm-170466</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/29125526/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3233/prm-170466" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="chu2020a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Chu DI, Liu T, Patel P, Routh JC, Ouyang L, Baum MA, <i>et al.</i></b></span>. <span style="font-variant: normal">Kidney Function Surveillance in the National Spina Bifida Patient Registry: A Retrospective Cohort Study</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2020; <b>204</b> (3)</span>: <span style="text-decoration: none">578–586</span>. <span style="text-decoration: underline">DOI: 10.1097/ju.0000000000001010</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/32141805/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/ju.0000000000001010" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="borer2017a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Borer JG, Vasquez E, Canning DA, Kryger JV, Bellows A, Weiss D, <i>et al.</i></b></span>. <span style="font-variant: normal">Commentary to “Short-term outcomes of the multi-institutional bladder exstrophy consortium: Successes and complications in the first two years of collaboration.”</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2017; <b>13</b> (3)</span>: <span style="text-decoration: none">276</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2017.01.022</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/28314702/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2017.01.022" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="weiss2020a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Weiss DA, Shukla AR, Borer JG, Sack BS, Kryger JV, Roth EB, <i>et al.</i></b></span>. <span style="font-variant: normal">Evaluation of outcomes following complete primary repair of bladder exstrophy at three individual sites prior to the establishment of a multi-institutional collaborative model</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2020; <b>16</b> (4)</span>: <span style="text-decoration: none">435.e1–435.e6</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2020.05.153</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/32616376/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2020.05.153" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="routh2016a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Routh JC, Cheng EY, Austin JC, Baum MA, Gargollo PC, Grady RW, <i>et al.</i></b></span>. <span style="font-variant: normal">Design and Methodological Considerations of the Centers for Disease Control and Prevention Urologic and Renal Protocol for the Newborn and Young Child with Spina Bifida</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2016; <b>196</b> (6)</span>: <span style="text-decoration: none">1728–1734</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2016.07.081</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/27475969/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2016.07.081" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="tanaka2019a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Tanaka ST, Paramsothy P, Thibadeau J, Wiener JS, Joseph DB, Cheng EY, <i>et al.</i></b></span>. <span style="font-variant: normal">Baseline Urinary Tract Imaging in Infants Enrolled in the UMPIRE Protocol for Children with Spina Bifida</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2019; <b>201</b> (6)</span>: <span style="text-decoration: none">1193–1198</span>. <span style="text-decoration: underline">DOI: 10.1097/ju.0000000000000141</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/30730412/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/ju.0000000000000141" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="wallis2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Wallis MC, Paramsothy P, Newsome K, Williams T, Routh JC, Joseph DB, <i>et al.</i></b></span>. <span style="font-variant: normal">Faculty Opinions recommendation of Incidence of Urinary Tract Infections in Newborns with Spina Bifida: Is Antibiotic Prophylaxis Necessary?</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature</i></span> <span style="text-decoration: none">2021; <b>06</b> (1)</span>: <span style="text-decoration: none">26–32</span>. <span style="text-decoration: underline">DOI: 10.3410/f.739703496.793583980</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/33683941/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3410/f.739703496.793583980" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="tanaka2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Tanaka ST, Yerkes EB, Routh JC, Tu DD, Austin JC, Wiener JS, <i>et al.</i></b></span>. <span style="font-variant: normal">Urodynamic characteristics of neurogenic bladder in newborns with myelomeningocele and refinement of the definition of bladder hostility: Findings from the UMPIRE multi-center study</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2021; <b>17</b> (5)</span>: <span style="text-decoration: none">726–732</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2021.04.019</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/34011486/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2021.04.019" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="avery2015a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Avery DI, Herbst KW, Lendvay TS, Noh PH, Dangle P, Gundeti MS, <i>et al.</i></b></span>. <span style="font-variant: normal">Commentary to “Robot-assisted laparoscopic pyeloplasty: Multi-institutional experience in infants.”</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2015; <b>11</b> (3)</span>: <span style="text-decoration: none">140</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2014.11.016</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/26052000/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2014.11.016" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="boysen2017a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Boysen WR, Ellison JS, Kim C, Koh CJ, Noh P, Whittam B, <i>et al.</i></b></span>. <span style="font-variant: normal">Multi-Institutional Review of Outcomes and Complications of Robot-Assisted Laparoscopic Extravesical Ureteral Reimplantation for Treatment of Primary Vesicoureteral Reflux in Children</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2017; <b>197</b> (6)</span>: <span style="text-decoration: none">1555–1561</span>. <span style="text-decoration: underline">DOI: 10.1016/j.juro.2017.01.062</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/28130103/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.juro.2017.01.062" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="boysen2018a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Boysen WR, Akhavan A, Ko J, Ellison JS, Lendvay TS, Huang J, <i>et al.</i></b></span>. <span style="font-variant: normal">Response to commentary to “Prospective multicenter study on robot-assisted laparoscopic extravesical ureteral reimplantation (RALUR-EV): Outcomes and complications.”</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2018; <b>14</b> (3)</span>: <span style="text-decoration: none">265–266</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2018.03.004</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/29503220/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2018.03.004" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="dangle2016a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Dangle PP, Akhavan A, Odeleye M, Avery D, Lendvay T, Koh CJ, <i>et al.</i></b></span>. <span style="font-variant: normal">Ninety-day perioperative complications of pediatric robotic urological surgery: A multi-institutional study</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2016; <b>12</b> (2)</span>: <span style="text-decoration: none">102.e1–102.e6</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2015.08.015</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/26897324/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2015.08.015" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="gundeti2016a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Gundeti MS, Petravick ME, Pariser JJ, Pearce SM, Anderson BB, Grimsby GM, <i>et al.</i></b></span>. <span style="font-variant: normal">A multi-institutional study of perioperative and functional outcomes for pediatric robotic-assisted laparoscopic Mitrofanoff appendicovesicostomy</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2016; <b>12</b> (6)</span>: <span style="text-decoration: none">386.e1–386.e5</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2016.05.031</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/27349147/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2016.05.031" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="mittal2022a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Mittal S, Aghababian A, Eftekharzadeh S, Saxena S, Janssen K, Lombardo A, <i>et al.</i></b></span>. <span style="font-variant: normal">Mp44-17\hspace1emRobot-assisted Laparoscopic Ureterocalicostomy In The Setting Of Ureteropelvic Junction Obstruction: A Multi-institutional Cohort</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2022; <b>206</b> (Supplement 3)</span>: <span style="text-decoration: none">80–85</span>. <span style="text-decoration: underline">DOI: 10.1097/ju.0000000000002065.17</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/35188821/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/ju.0000000000002065.17" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="vemulakonda2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Vemulakonda VM, Sevick C, Juarez-Colunga E, Chiang G, Janzen N, Saville A, <i>et al.</i></b></span>. <span style="font-variant: normal">Treatment of infants with ureteropelvic junction obstruction: findings from the PURSUIT network</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Int Urol Nephrol</i></span> <span style="text-decoration: none">2021; <b>53</b> (8)</span>: <span style="text-decoration: none">1485–1495</span>. <span style="text-decoration: underline">DOI: 10.1007/s11255-021-02866-y</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/33948809/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1007/s11255-021-02866-y" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="vemulakonda2022a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Vemulakonda VM, Janzen N, Hittelman AB, Deakyne Davies S, Sevick C, Richardson AC, <i>et al.</i></b></span>. <span style="font-variant: normal">Feasibility of establishing a multi-center research database using the electronic health record: The PURSUIT network</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2022; <b>18</b> (6)</span>: <span style="text-decoration: none">788.e1–788.e8</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2022.05.004</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/35644792/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2022.05.004" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="szymanski2019a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Szymanski KM, Fuchs M, McLeod D, Rosoklija I, Strine AC, VanderBrink B, <i>et al.</i></b></span>. <span style="font-variant: normal">Faculty Opinions recommendation of Probability of Bladder Augmentation, Diversion and Clean Intermittent Catheterization in Classic Bladder Exstrophy: A 36-Year, Multi-Institutional, Retrospective Cohort Study.</span> <span style="text-decoration: underline"><span style="text-decoration: none"><i>Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature</i></span> <span style="text-decoration: none">2019; <b>02</b> (6)</span>: <span style="text-decoration: none">256–262</span>. <span style="text-decoration: underline">DOI: 10.3410/f.736628511.793569970</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/31526259/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.3410/f.736628511.793569970" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="mcleod2019a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>McLeod DJ, Szymanski KM, Gong E, Granberg C, Reddy P, Sebastião Y, <i>et al.</i></b></span>. <span style="font-variant: normal">Renal Replacement Therapy and Intermittent Catheterization Risk in Posterior Urethral Valves</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatrics</i></span> <span style="text-decoration: none">2019; <b>143</b> (3)</span>: <span style="text-decoration: none">20182656</span>. <span style="text-decoration: underline">DOI: 10.1542/peds.2018-2656</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/30709926/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1542/peds.2018-2656" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="fuchs2023a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Fuchs ME, Ahmed M, Dajusta DG, Gargollo P, Kennedy UK, Rosoklija I, <i>et al.</i></b></span>. <span style="font-variant: normal">Urinary and bowel management in cloacal exstrophy: A long-term multi-institutional cross-sectional study</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2023; <b>19</b> (1)</span>: <span style="text-decoration: none">35.e1–35.e6</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2022.10.003</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/36273977/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2022.10.003" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="mcleod2018a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>McLeod D, VanderBrink B, Szymanski K, Fuchs M, Gargollo P, Granberg C, <i>et al.</i></b></span>. <span style="font-variant: normal">Presentation, management, and outcome of posterior urethral valves in a Nigerian tertiary hospital</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Afr J Paediatr Surg</i></span> <span style="text-decoration: none">2018; <b>12</b> (1)</span>: <span style="text-decoration: none">18</span>. <span style="text-decoration: underline">DOI: 10.4103/0189-6725.150937</span></span>.</span></span>   <a href="https://doi.org/10.4103/0189-6725.150937" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="mcleod-a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>McLeod DJ, Rehfuss A, Reddy P, Granberg C, VanderBrink B, Whittam B, <i>et al.</i></b></span>. Collaboration and Standardized Management Plans to optimize clinical care and research of Posterior Urethral Valves. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatric Urology Fall Congress. Scientific Session 1: Fetal Urology/Hydronephrosis/Obstructive Uropathy. 2019 Sept 26</i></span>. <span style="text-decoration: none">Scottsdale, AZ: </span></span>.</span></span> </li>
<li>
<span id="kaefer2022a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Kaefer M, Saad K, Gargollo P, Whittam B, Rink R, Fuchs M, <i>et al.</i></b></span>. <span style="font-variant: normal">Intraoperative laser angiography in bladder exstrophy closure: A simple technique to monitor penile perfusion</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2022; <b>18</b> (6)</span>: <span style="text-decoration: none">746.e1–746.e7</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2022.10.012</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/36336625/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2022.10.012" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="cd2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Scales CD, Desai AC, Harper JD, Lai HH, Maalouf NM, Reese PP, <i>et al.</i></b></span>. <span style="font-variant: normal">Prevention of Urinary Stones With Hydration (PUSH): Design and Rationale of a Clinical Trial</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Am J Kidney Dis</i></span> <span style="text-decoration: none">2021; <b>77</b> (6)</span>: <span style="text-decoration: none">898–906.e1</span>. <span style="text-decoration: underline">DOI: 10.1053/j.ajkd.2020.09.016</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/33212205/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1053/j.ajkd.2020.09.016" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="unknown2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Investigators TUSDRN(USDRN</b></span>. <span style="font-variant: normal">Impact of COVID-19 on Prevention of Urinary Stones with Hydration (PUSH) Study: Challenges and Opportunities for Future Trials</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2021; <b>206</b> (3)</span>: <span style="text-decoration: none">502–504</span>. <span style="text-decoration: underline">DOI: 10.1097/ju.0000000000001833</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/33908800/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/ju.0000000000001833" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="rove2020a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Rove KO, Strine AC, Wilcox DT, Vricella GJ, Welch TP, VanderBrink B, <i>et al.</i></b></span>. <span style="font-variant: normal">Design and development of the Pediatric Urology Recovery After Surgery Endeavor (PURSUE) multicentre pilot and exploratory study</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>BMJ Open</i></span> <span style="text-decoration: none">2020; <b>10</b> (11)</span>: <span style="text-decoration: none">e039035</span>. <span style="text-decoration: underline">DOI: 10.1136/bmjopen-2020-039035</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/33234633/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1136/bmjopen-2020-039035" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="moore2023a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Moore RP, Burjek NE, Brockel MA, Strine AC, Acks A, Boxley PJ, <i>et al.</i></b></span>. <span style="font-variant: normal">Evaluating the role for regional analgesia in children with spina bifida: a retrospective observational study comparing the efficacy of regional versus systemic analgesia protocols following major urological surgery</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Reg Anesth Pain Med</i></span> <span style="text-decoration: none">2023; <b>48</b> (1)</span>: <span style="text-decoration: none">29–36</span>. <span style="text-decoration: underline">DOI: 10.1136/rapm-2022-103823</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/36167478/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1136/rapm-2022-103823" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="tasian2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Tasian GE, Ellison JS, Network TPKIDS(PKIDSCI</b></span>. <span style="font-variant: normal">The Surgical Improvement Cycle: Improving Surgical Outcomes through Partnerships and Rigor</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Urol</i></span> <span style="text-decoration: none">2021; <b>205</b> (6)</span>: <span style="text-decoration: none">1554–1556</span>. <span style="text-decoration: underline">DOI: 10.1097/ju.0000000000001626</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/33502238/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1097/ju.0000000000001626" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="ellison2022a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Ellison JS, Lorenzo M, Beck H, Beck R, Chu DI, Forrest C, <i>et al.</i></b></span>. <span style="font-variant: normal">Comparative effectiveness of paediatric kidney stone surgery (the PKIDS trial): study protocol for a patient-centred pragmatic clinical trial</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>BMJ Open</i></span> <span style="text-decoration: none">2022; <b>12</b> (4)</span>: <span style="text-decoration: none">e056789</span>. <span style="text-decoration: underline">DOI: 10.1136/bmjopen-2021-056789</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/35383073/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1136/bmjopen-2021-056789" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="holzman2021b"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Holzman SA, Ahn JJ, Baker Z, Chuang K-wen, Copp HL, Davidson J, <i>et al.</i></b></span>. <span style="font-variant: normal">A multicenter study of acute testicular torsion in the time of COVID-19</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2021; <b>17</b> (4)</span>: <span style="text-decoration: none">478.e1–478.e6</span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2021.03.013</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/33832873/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2021.03.013" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="yamashiro2023a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Yamashiro JR, Austin JC, Braga LH, Chuang K-W, Davis-Dao CA, Hecht S, <i>et al.</i></b></span>. <span style="font-variant: normal">Identifying variability in surgical practices and instrumentation for hypospadias repair across the Western Pediatric Urology Consortium (WPUC) network</span>. <span style="text-decoration: underline"><span style="text-decoration: none"><i>J Pediatr Urol</i></span> <span style="text-decoration: none">2023; <b>11:s1477-5131(22)00575-7</b></span>. <span style="text-decoration: underline">DOI: 10.1016/j.jpurol.2022.12.001</span></span>.</span></span>   <a href="https://pubmed.ncbi.nlm.nih.gov/36775718/" title="" data-pubmed="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to PubMed"><i class="ai2 ai-pubmed"></i></a> <a href="https://doi.org/10.1016/j.jpurol.2022.12.001" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="lucas2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Lucas JW, Tong CMC, Bhatia V, Ellis JL, Abelson B, Lee AS, <i>et al.</i></b></span>. Follow-up Patterns and Post-injury Phsical Activity Recommendations in Pediatric High-grade Renal Trauma: A Multicenter. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Retrospective Analysis from the Traumatic Renal Injury Collaborative in Kids (TRICK) Consortium. Annual Meeting of the American Urologic Association. Pediatric Urology III</i></span>. <span style="text-decoration: none">2021</span></span>.</span></span> </li>
<li>
<span id="lee2021a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Lee AST, Tong CMC, Lucas JW, Bhatia VP, Mecca D, Abelson B, <i>et al.</i></b></span>. Does Race and Insurance Status Play a Role in High-Grade Renal Trauma in the Pediatric Population? <span style="text-decoration: underline"><span style="text-decoration: none"><i>An Analysis from the Traumatic Renal Injury Collaborative in Kids (TRICK) consortium. Pediatric Urology Fall Congress. Scientific Session II: Miscellaneous</i></span>. <span style="text-decoration: none">Miami, FL: 2021</span></span>.</span></span> </li>
<li>
<span id="tong2022a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Tong CMC, Lucas J, Lee A, Bhatia V, Abelson B, Long C, <i>et al.</i></b></span>. Is Excretory Phase Computerized Tomography Important for Evaluation of High Grade Renal Trauma?: Results from the Traumatic Renal Injury Collaboration for Kids (TRICK. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Annual Meeting of the American Urologic Association. Pediatric Urology: Upper \\&amp; Lower Urinary Tract</i></span>. <span style="text-decoration: none">New Orleans, LA: 2022</span>. DOI: 10.1097/ju.0000000000002550.14</span>.</span></span>  <a href="https://doi.org/10.1097/ju.0000000000002550.14" title="" data-doi="1" data-toggle="tooltip" data-placement="top" data-original-title="Link to DOI"><i class="ai2 ai-doi"></i></a>
</li>
<li>
<span id="flores2022a"><span style="font-weight: normal; text-decoration: none"><span style="font-weight: normal"><b>Flores A VX, B Z, S K, G K, CB L, H G, <i>et al.</i></b></span>. Isolated Intra-abdominal Renal Trauma is Not Associated with Reduced Complications, Readmissions, or Delayed Interventions. <span style="text-decoration: underline"><span style="text-decoration: none"><i>Pediatric Urology Fall Congress</i></span>. <span style="text-decoration: none">Las Vegas, NV.: Miscellaneous; 2022</span></span>.</span></span> </li>
</ol>


            
            <!--Last repository commit: b37c1630-->
            <p class="last-modified"><i class="fas fa-clock pr-2"></i><em>Last updated: 2023-04-23 01:31</em></p>
          </div> <!-- /col -->
        </div> <!-- /row -->
      </div> <!-- /container -->
    </div> <!-- /main -->
    
    <footer id="footer">
      <div class="container">
        <div class="row py-5">
          <div class="col-md-4 d-flex justify-content-center justify-content-md-start mb-4 mb-lg-0">
            <a href="https://beta.pediatricurologybook.com/" class="logo pr-0 pr-lg-3 pl-3 pl-md-0">
                <img alt="Pediatric Urology Book" class="img-responsive" src="https://beta.pediatricurologybook.com/assets/site-img/pediatricurologybook-white.svg">
            </a>
          </div>
        </div>
      </div>
      <div class="footer-copyright footer-copyright-style-2">
        <div class="container py-2">
          <div class="row py-4">
            <div class="col-lg-4 d-flex align-items-end justify-content-center justify-content-md-start mb-2 mb-lg-0">
              <p>© 2023 by <a href="https://beta.pediatricurologybook.com/">Pediatric Urology Book</a>. All Rights Reserved.</p>
            </div>
            <div class="col-lg-8 d-flex flex-column mb-4 mb-lg-0">
              <div class="row">
                <div class="col-12 d-flex align-items-center justify-content-center justify-content-md-end m-0 p-0"><ul class="footer-social-icons social-icons social-icons-clean social-icons-icon-light"><li class="social-icons-github"><a href="https://www.github.com/kylerove/pediatricurologybook" target="_blank" title="GitHub"><i class="fab fa-github-alt"></i></a></li><li class="social-icons-twitter"><a href="https://www.twitter.com/PedUrologyBook" target="_blank" title="Twitter"><i class="fab fa-twitter"></i></a></li><li class="social-icons-mastodon"><a rel="me" href="https://med-mastodon.com/@pediatricurologybook" target="_blank" title="Mastodon"><i class="fab fa-mastodon"></i></a></li><li class="social-icons-youtube"><a href="https://www.youtube.com/@pediatricurologybook" target="_blank" title="Youtube"><i class="fab fa-youtube"></i></a></li></ul></div>
              </div>
              <div class="row">
                <div class="col-12 d-flex align-items-center justify-content-center justify-content-md-end m-0 p-0">
                  <nav id="sub-menu">
                    <ul>
                      <li><i class="fas fa-map-marker"></i> <a href="https://beta.pediatricurologybook.com/site-map/">Site Map</a></li><li><i class="fas fa-envelope"></i><a href="mailto:editors%40pediatricurologybook.com" class="opacity-7 pl-1">editors@pediatricurologybook.com</a></li></ul>
                  </nav>
                </div>
              </div>
            </div>
          </div>
        </div>
      </div>
    </footer>
</div>
    
    <!-- Search -->
    <script src="https://beta.pediatricurologybook.com/assets/js/search.min.js"></script>
    
    <!-- Vendor -->
    <script src="https://beta.pediatricurologybook.com/assets/vendor/jquery/jquery.min.js"></script>
    <script src="https://beta.pediatricurologybook.com/assets/vendor/jquery.appear/jquery.appear.min.js"></script>
    <script src="https://beta.pediatricurologybook.com/assets/vendor/jquery.easing/jquery.easing.min.js"></script>
    <script src="https://beta.pediatricurologybook.com/assets/vendor/jquery.validation/jquery.validate.min.js"></script>
    <script src="https://beta.pediatricurologybook.com/assets/vendor/jquery.stupidtable/stupidtable.min.js"></script>
    <script src="https://beta.pediatricurologybook.com/assets/vendor/popper/umd/popper.min.js"></script>
    <script src="https://beta.pediatricurologybook.com/assets/vendor/bootstrap/js/bootstrap.min.js"></script>
    
    <!-- Theme Base, Components and Settings -->
    <script src="https://beta.pediatricurologybook.com/assets/js/theme.js"></script>
    
    <!-- Current Page --><script src="https://beta.pediatricurologybook.com/assets/js/pages/chapter.js"></script>
    
    
    <!-- Theme Custom -->
    <script src="https://beta.pediatricurologybook.com/assets/js/custom.js"></script>
    
    <!-- Theme Initialization Files -->
    <script src="https://beta.pediatricurologybook.com/assets/js/theme.init.js"></script>
    
    <!-- Scroll to top -->
    <a class="scroll-to-top hidden-mobile" href="#"><i class="fas fa-chevron-up"></i></a>
    
  </body>
</html>
